assertEquals(expectedErrorMsg, parsedErrorResponse);
}
- @Test(groups = { "External" }, expectedExceptions = Exception.class)
+ @Test(groups = { "External" }, enabled = false, expectedExceptions = Exception.class)
public void testForExpectedRuntimeException() throws Exception
{
- // JBPNote: looks like this test fails for no good reason - what exception was supposed to be raised ?
+ // FIXME JBPNote: looks like this test fails for no good reason - what exception was supposed to be raised ?
List<FTSDataColumnI> wantedFields = new ArrayList<FTSDataColumnI>();
wantedFields.add(PDBFTSRestClient.getInstance()
.getDataColumnByNameOrCode("pdb_id"));
public static void setMock()
{
String[][] mocks = new String[2][];
- mocks[0] = new String[] {
- "https://www.ebi.ac.uk/pdbe/search/pdb/select?wt=json&fl=pdb_id,title,experimental_method,resolution&rows=500&start=0&q=(4igk+OR+1t15+OR+4ifi+OR+1t29+OR+3pxb+OR+4y2g+OR+1y98+OR+1jnx+OR+3pxa+OR+3k0h+OR+3k0k+OR+1n5o+OR+3pxc+OR+3pxd+OR+1t2u+OR+3k15+OR+3pxe+OR+3k16+OR+4ofb+OR+3coj+OR+7lyb+OR+1t2v+OR+4y18+OR+4jlu+OR+4u4a+OR+2ing+OR+7jzv+OR+6g2i+OR+1jm7+OR+1oqa)+AND+molecule_sequence:%5B''+TO+*%5D+AND+status:REL&sort=",
- "{\n" + " \"responseHeader\":{\n" + " \"status\":0,\n"
- + " \"QTime\":0,\n" + " \"params\":{\n"
- + " \"q\":\"(4igk OR 1t15 OR 4ifi OR 1t29 OR 3pxb OR 4y2g OR 1y98 OR 1jnx OR 3pxa OR 3k0h OR 3k0k OR 1n5o OR 3pxc OR 3pxd OR 1t2u OR 3k15 OR 3pxe OR 3k16 OR 4ofb OR 3coj OR 7lyb OR 1t2v OR 4y18 OR 4jlu OR 4u4a OR 2ing OR 7jzv OR 6g2i OR 1jm7 OR 1oqa) AND molecule_sequence:['' TO *] AND status:REL\",\n"
- + " \"fl\":\"pdb_id,title,experimental_method,resolution\",\n"
- + " \"start\":\"0\",\n" + " \"sort\":\"\",\n"
- + " \"rows\":\"500\",\n" + " \"wt\":\"json\"}},\n"
- + " \"response\":{\"numFound\":64,\"start\":0,\"docs\":[\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"4ofb\",\n"
- + " \"resolution\":3.05,\n"
- + " \"title\":\"Crystal structure of human BRCA1 BRCT in complex with nonphosphopeptide inhibitor\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"3pxe\",\n"
- + " \"resolution\":2.85,\n"
- + " \"title\":\"Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: E1836K\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"4jlu\",\n"
- + " \"resolution\":3.5,\n"
- + " \"title\":\"Crystal structure of BRCA1 BRCT with doubly phosphorylated Abraxas\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"4y2g\",\n"
- + " \"resolution\":2.5,\n"
- + " \"title\":\"Structure of BRCA1 BRCT domains in complex with Abraxas single phosphorylated peptide\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"Solution NMR\"],\n"
- + " \"pdb_id\":\"1oqa\",\n"
- + " \"title\":\"Solution structure of the BRCT-c domain from human BRCA1\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"4u4a\",\n"
- + " \"resolution\":3.51,\n"
- + " \"title\":\"Complex Structure of BRCA1 BRCT with singly phospho Abraxas\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"1t2v\",\n"
- + " \"resolution\":3.3,\n"
- + " \"title\":\"Structural basis of phospho-peptide recognition by the BRCT domain of BRCA1, structure with phosphopeptide\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"3k15\",\n"
- + " \"resolution\":2.8,\n"
- + " \"title\":\"Crystal Structure of BRCA1 BRCT D1840T in complex with a minimal recognition tetrapeptide with an amidated C-terminus\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"1t15\",\n"
- + " \"resolution\":1.85,\n"
- + " \"title\":\"Crystal Structure of the Brca1 BRCT Domains in Complex with the Phosphorylated Interacting Region from Bach1 Helicase\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"3k16\",\n"
- + " \"resolution\":3.0,\n"
- + " \"title\":\"Crystal Structure of BRCA1 BRCT D1840T in complex with a minimal recognition tetrapeptide with a free carboxy C-terminus\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"1t29\",\n"
- + " \"resolution\":2.3,\n"
- + " \"title\":\"Crystal structure of the BRCA1 BRCT repeats bound to a phosphorylated BACH1 peptide\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"1y98\",\n"
- + " \"resolution\":2.5,\n"
- + " \"title\":\"Structure of the BRCT repeats of BRCA1 bound to a CtIP phosphopeptide.\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"4ifi\",\n"
- + " \"resolution\":2.2,\n"
- + " \"title\":\"Structure of human BRCA1 BRCT in complex with BAAT peptide\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"3k0k\",\n"
- + " \"resolution\":2.7,\n"
- + " \"title\":\"Crystal Structure of BRCA1 BRCT in complex with a minimal recognition tetrapeptide with a free carboxy C-terminus.\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"3k0h\",\n"
- + " \"resolution\":2.7,\n"
- + " \"title\":\"The crystal structure of BRCA1 BRCT in complex with a minimal recognition tetrapeptide with an amidated C-terminus\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"3pxd\",\n"
- + " \"resolution\":2.8,\n"
- + " \"title\":\"Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: R1835P\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"3pxc\",\n"
- + " \"resolution\":2.8,\n"
- + " \"title\":\"Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: R1699Q\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"3pxa\",\n"
- + " \"resolution\":2.55,\n"
- + " \"title\":\"Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: G1656D\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"1jnx\",\n"
- + " \"resolution\":2.5,\n"
- + " \"title\":\"Crystal structure of the BRCT repeat region from the breast cancer associated protein, BRCA1\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"4igk\",\n"
- + " \"resolution\":1.75,\n"
- + " \"title\":\"Structure of human BRCA1 BRCT in complex with ATRIP peptide\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"Solution NMR\"],\n"
- + " \"pdb_id\":\"1jm7\",\n"
- + " \"title\":\"Solution structure of the BRCA1/BARD1 RING-domain heterodimer\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"4jlu\",\n"
- + " \"resolution\":3.5,\n"
- + " \"title\":\"Crystal structure of BRCA1 BRCT with doubly phosphorylated Abraxas\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"Electron Microscopy\"],\n"
- + " \"pdb_id\":\"6g2i\",\n"
- + " \"resolution\":5.9,\n"
- + " \"title\":\"Filament of acetyl-CoA carboxylase and BRCT domains of BRCA1 (ACC-BRCT) at 5.9 A resolution\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"3coj\",\n"
- + " \"resolution\":3.21,\n"
- + " \"title\":\"Crystal Structure of the BRCT Domains of Human BRCA1 in Complex with a Phosphorylated Peptide from Human Acetyl-CoA Carboxylase 1\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"3pxb\",\n"
- + " \"resolution\":2.5,\n"
- + " \"title\":\"Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: T1700A\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"1t2u\",\n"
- + " \"resolution\":2.8,\n"
- + " \"title\":\"Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1: structure of BRCA1 missense variant V1809F\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"1n5o\",\n"
- + " \"resolution\":2.8,\n"
- + " \"title\":\"Structural consequences of a cancer-causing BRCA1-BRCT missense mutation\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"4u4a\",\n"
- + " \"resolution\":3.51,\n"
- + " \"title\":\"Complex Structure of BRCA1 BRCT with singly phospho Abraxas\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"4y2g\",\n"
- + " \"resolution\":2.5,\n"
- + " \"title\":\"Structure of BRCA1 BRCT domains in complex with Abraxas single phosphorylated peptide\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"3pxe\",\n"
- + " \"resolution\":2.85,\n"
- + " \"title\":\"Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: E1836K\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"4ofb\",\n"
- + " \"resolution\":3.05,\n"
- + " \"title\":\"Crystal structure of human BRCA1 BRCT in complex with nonphosphopeptide inhibitor\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"4y18\",\n"
- + " \"resolution\":3.5,\n"
- + " \"title\":\"Structure of BRCA1 BRCT domains in complex with Abraxas double phosphorylated peptide\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"2ing\",\n"
- + " \"resolution\":3.6,\n"
- + " \"title\":\"X-ray Structure of the BRCA1 BRCT mutant M1775K\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"1t29\",\n"
- + " \"resolution\":2.3,\n"
- + " \"title\":\"Crystal structure of the BRCA1 BRCT repeats bound to a phosphorylated BACH1 peptide\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"1t2v\",\n"
- + " \"resolution\":3.3,\n"
- + " \"title\":\"Structural basis of phospho-peptide recognition by the BRCT domain of BRCA1, structure with phosphopeptide\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"1t15\",\n"
- + " \"resolution\":1.85,\n"
- + " \"title\":\"Crystal Structure of the Brca1 BRCT Domains in Complex with the Phosphorylated Interacting Region from Bach1 Helicase\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"Solution NMR\"],\n"
- + " \"pdb_id\":\"1jm7\",\n"
- + " \"title\":\"Solution structure of the BRCA1/BARD1 RING-domain heterodimer\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"4ifi\",\n"
- + " \"resolution\":2.2,\n"
- + " \"title\":\"Structure of human BRCA1 BRCT in complex with BAAT peptide\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"4igk\",\n"
- + " \"resolution\":1.75,\n"
- + " \"title\":\"Structure of human BRCA1 BRCT in complex with ATRIP peptide\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"1y98\",\n"
- + " \"resolution\":2.5,\n"
- + " \"title\":\"Structure of the BRCT repeats of BRCA1 bound to a CtIP phosphopeptide.\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"3k15\",\n"
- + " \"resolution\":2.8,\n"
- + " \"title\":\"Crystal Structure of BRCA1 BRCT D1840T in complex with a minimal recognition tetrapeptide with an amidated C-terminus\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"3k0k\",\n"
- + " \"resolution\":2.7,\n"
- + " \"title\":\"Crystal Structure of BRCA1 BRCT in complex with a minimal recognition tetrapeptide with a free carboxy C-terminus.\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"3k16\",\n"
- + " \"resolution\":3.0,\n"
- + " \"title\":\"Crystal Structure of BRCA1 BRCT D1840T in complex with a minimal recognition tetrapeptide with a free carboxy C-terminus\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"3k0h\",\n"
- + " \"resolution\":2.7,\n"
- + " \"title\":\"The crystal structure of BRCA1 BRCT in complex with a minimal recognition tetrapeptide with an amidated C-terminus\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"4y18\",\n"
- + " \"resolution\":3.5,\n"
- + " \"title\":\"Structure of BRCA1 BRCT domains in complex with Abraxas double phosphorylated peptide\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"X-ray diffraction\"],\n"
- + " \"pdb_id\":\"3coj\",\n"
- + " \"resolution\":3.21,\n"
- + " \"title\":\"Crystal Structure of the BRCT Domains of Human BRCA1 in Complex with a Phosphorylated Peptide from Human Acetyl-CoA Carboxylase 1\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"Electron Microscopy\"],\n"
- + " \"pdb_id\":\"7jzv\",\n"
- + " \"resolution\":3.9,\n"
- + " \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"Electron Microscopy\"],\n"
- + " \"pdb_id\":\"7jzv\",\n"
- + " \"resolution\":3.9,\n"
- + " \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"Electron Microscopy\"],\n"
- + " \"pdb_id\":\"7lyb\",\n"
- + " \"resolution\":3.28,\n"
- + " \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"Electron Microscopy\"],\n"
- + " \"pdb_id\":\"7lyb\",\n"
- + " \"resolution\":3.28,\n"
- + " \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"Electron Microscopy\"],\n"
- + " \"pdb_id\":\"7lyb\",\n"
- + " \"resolution\":3.28,\n"
- + " \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"Electron Microscopy\"],\n"
- + " \"pdb_id\":\"7jzv\",\n"
- + " \"resolution\":3.9,\n"
- + " \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"Electron Microscopy\"],\n"
- + " \"pdb_id\":\"7lyb\",\n"
- + " \"resolution\":3.28,\n"
- + " \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"Electron Microscopy\"],\n"
- + " \"pdb_id\":\"7jzv\",\n"
- + " \"resolution\":3.9,\n"
- + " \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"Electron Microscopy\"],\n"
- + " \"pdb_id\":\"7lyb\",\n"
- + " \"resolution\":3.28,\n"
- + " \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"Electron Microscopy\"],\n"
- + " \"pdb_id\":\"7jzv\",\n"
- + " \"resolution\":3.9,\n"
- + " \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"Electron Microscopy\"],\n"
- + " \"pdb_id\":\"7lyb\",\n"
- + " \"resolution\":3.28,\n"
- + " \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"Electron Microscopy\"],\n"
- + " \"pdb_id\":\"7lyb\",\n"
- + " \"resolution\":3.28,\n"
- + " \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"Electron Microscopy\"],\n"
- + " \"pdb_id\":\"7lyb\",\n"
- + " \"resolution\":3.28,\n"
- + " \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"Electron Microscopy\"],\n"
- + " \"pdb_id\":\"7jzv\",\n"
- + " \"resolution\":3.9,\n"
- + " \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"Electron Microscopy\"],\n"
- + " \"pdb_id\":\"6g2i\",\n"
- + " \"resolution\":5.9,\n"
- + " \"title\":\"Filament of acetyl-CoA carboxylase and BRCT domains of BRCA1 (ACC-BRCT) at 5.9 A resolution\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"Electron Microscopy\"],\n"
- + " \"pdb_id\":\"7jzv\",\n"
- + " \"resolution\":3.9,\n"
- + " \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"Electron Microscopy\"],\n"
- + " \"pdb_id\":\"7lyb\",\n"
- + " \"resolution\":3.28,\n"
- + " \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
- + " {\n"
- + " \"experimental_method\":[\"Electron Microscopy\"],\n"
- + " \"pdb_id\":\"7jzv\",\n"
- + " \"resolution\":3.9,\n"
- + " \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"}]\n"
- + " }}" };
+ mocks[0] = new String[] {"https://www.ebi.ac.uk/pdbe/search/pdb/select?wt=json&fl=pdb_id,title,experimental_method,resolution&rows=500&start=0&q=(4igk+OR+7lyb+OR+3k0h+OR+3k0k+OR+1t15+OR+3pxc+OR+3pxd+OR+3pxe+OR+1jm7+OR+7jzv+OR+3pxa+OR+3pxb+OR+1y98+OR+1n5o+OR+4ifi+OR+4y2g+OR+3k15+OR+3k16+OR+4jlu+OR+2ing+OR+4ofb+OR+6g2i+OR+3coj+OR+1jnx+OR+4y18+OR+4u4a+OR+1oqa+OR+1t29+OR+1t2u+OR+1t2v)+AND+molecule_sequence:%5B''+TO+*%5D+AND+status:REL&sort=",
+ "{\n"
+ + " \"responseHeader\":{\n"
+ + " \"status\":0,\n"
+ + " \"QTime\":0,\n"
+ + " \"params\":{\n"
+ + " \"q\":\"(4igk OR 7lyb OR 3k0h OR 3k0k OR 1t15 OR 3pxc OR 3pxd OR 3pxe OR 1jm7 OR 7jzv OR 3pxa OR 3pxb OR 1y98 OR 1n5o OR 4ifi OR 4y2g OR 3k15 OR 3k16 OR 4jlu OR 2ing OR 4ofb OR 6g2i OR 3coj OR 1jnx OR 4y18 OR 4u4a OR 1oqa OR 1t29 OR 1t2u OR 1t2v) AND molecule_sequence:['' TO *] AND status:REL\",\n"
+ + " \"fl\":\"pdb_id,title,experimental_method,resolution\",\n"
+ + " \"start\":\"0\",\n"
+ + " \"sort\":\"\",\n"
+ + " \"rows\":\"500\",\n"
+ + " \"wt\":\"json\"}},\n"
+ + " \"response\":{\"numFound\":64,\"start\":0,\"docs\":[\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"4ofb\",\n"
+ + " \"resolution\":3.05,\n"
+ + " \"title\":\"Crystal structure of human BRCA1 BRCT in complex with nonphosphopeptide inhibitor\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"3pxe\",\n"
+ + " \"resolution\":2.85,\n"
+ + " \"title\":\"Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: E1836K\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"4jlu\",\n"
+ + " \"resolution\":3.5,\n"
+ + " \"title\":\"Crystal structure of BRCA1 BRCT with doubly phosphorylated Abraxas\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"4y2g\",\n"
+ + " \"resolution\":2.5,\n"
+ + " \"title\":\"Structure of BRCA1 BRCT domains in complex with Abraxas single phosphorylated peptide\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"Solution NMR\"],\n"
+ + " \"pdb_id\":\"1oqa\",\n"
+ + " \"title\":\"Solution structure of the BRCT-c domain from human BRCA1\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"4u4a\",\n"
+ + " \"resolution\":3.51,\n"
+ + " \"title\":\"Complex Structure of BRCA1 BRCT with singly phospho Abraxas\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"3k16\",\n"
+ + " \"resolution\":3.0,\n"
+ + " \"title\":\"Crystal Structure of BRCA1 BRCT D1840T in complex with a minimal recognition tetrapeptide with a free carboxy C-terminus\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"1t15\",\n"
+ + " \"resolution\":1.85,\n"
+ + " \"title\":\"Crystal Structure of the Brca1 BRCT Domains in Complex with the Phosphorylated Interacting Region from Bach1 Helicase\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"3k15\",\n"
+ + " \"resolution\":2.8,\n"
+ + " \"title\":\"Crystal Structure of BRCA1 BRCT D1840T in complex with a minimal recognition tetrapeptide with an amidated C-terminus\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"1t2v\",\n"
+ + " \"resolution\":3.3,\n"
+ + " \"title\":\"Structural basis of phospho-peptide recognition by the BRCT domain of BRCA1, structure with phosphopeptide\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"1y98\",\n"
+ + " \"resolution\":2.5,\n"
+ + " \"title\":\"Structure of the BRCT repeats of BRCA1 bound to a CtIP phosphopeptide.\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"1t29\",\n"
+ + " \"resolution\":2.3,\n"
+ + " \"title\":\"Crystal structure of the BRCA1 BRCT repeats bound to a phosphorylated BACH1 peptide\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"3k0k\",\n"
+ + " \"resolution\":2.7,\n"
+ + " \"title\":\"Crystal Structure of BRCA1 BRCT in complex with a minimal recognition tetrapeptide with a free carboxy C-terminus.\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"3k0h\",\n"
+ + " \"resolution\":2.7,\n"
+ + " \"title\":\"The crystal structure of BRCA1 BRCT in complex with a minimal recognition tetrapeptide with an amidated C-terminus\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"4ifi\",\n"
+ + " \"resolution\":2.2,\n"
+ + " \"title\":\"Structure of human BRCA1 BRCT in complex with BAAT peptide\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"3pxd\",\n"
+ + " \"resolution\":2.8,\n"
+ + " \"title\":\"Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: R1835P\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"3pxc\",\n"
+ + " \"resolution\":2.8,\n"
+ + " \"title\":\"Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: R1699Q\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"1jnx\",\n"
+ + " \"resolution\":2.5,\n"
+ + " \"title\":\"Crystal structure of the BRCT repeat region from the breast cancer associated protein, BRCA1\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"3pxa\",\n"
+ + " \"resolution\":2.55,\n"
+ + " \"title\":\"Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: G1656D\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"Solution NMR\"],\n"
+ + " \"pdb_id\":\"1jm7\",\n"
+ + " \"title\":\"Solution structure of the BRCA1/BARD1 RING-domain heterodimer\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"4igk\",\n"
+ + " \"resolution\":1.75,\n"
+ + " \"title\":\"Structure of human BRCA1 BRCT in complex with ATRIP peptide\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"1t2u\",\n"
+ + " \"resolution\":2.8,\n"
+ + " \"title\":\"Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1: structure of BRCA1 missense variant V1809F\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"3pxb\",\n"
+ + " \"resolution\":2.5,\n"
+ + " \"title\":\"Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: T1700A\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"1n5o\",\n"
+ + " \"resolution\":2.8,\n"
+ + " \"title\":\"Structural consequences of a cancer-causing BRCA1-BRCT missense mutation\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"3coj\",\n"
+ + " \"resolution\":3.21,\n"
+ + " \"title\":\"Crystal Structure of the BRCT Domains of Human BRCA1 in Complex with a Phosphorylated Peptide from Human Acetyl-CoA Carboxylase 1\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"Electron Microscopy\"],\n"
+ + " \"pdb_id\":\"6g2i\",\n"
+ + " \"resolution\":5.9,\n"
+ + " \"title\":\"Filament of acetyl-CoA carboxylase and BRCT domains of BRCA1 (ACC-BRCT) at 5.9 A resolution\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"4jlu\",\n"
+ + " \"resolution\":3.5,\n"
+ + " \"title\":\"Crystal structure of BRCA1 BRCT with doubly phosphorylated Abraxas\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"4ofb\",\n"
+ + " \"resolution\":3.05,\n"
+ + " \"title\":\"Crystal structure of human BRCA1 BRCT in complex with nonphosphopeptide inhibitor\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"3pxe\",\n"
+ + " \"resolution\":2.85,\n"
+ + " \"title\":\"Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: E1836K\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"4u4a\",\n"
+ + " \"resolution\":3.51,\n"
+ + " \"title\":\"Complex Structure of BRCA1 BRCT with singly phospho Abraxas\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"4y2g\",\n"
+ + " \"resolution\":2.5,\n"
+ + " \"title\":\"Structure of BRCA1 BRCT domains in complex with Abraxas single phosphorylated peptide\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"4y18\",\n"
+ + " \"resolution\":3.5,\n"
+ + " \"title\":\"Structure of BRCA1 BRCT domains in complex with Abraxas double phosphorylated peptide\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"2ing\",\n"
+ + " \"resolution\":3.6,\n"
+ + " \"title\":\"X-ray Structure of the BRCA1 BRCT mutant M1775K\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"1t15\",\n"
+ + " \"resolution\":1.85,\n"
+ + " \"title\":\"Crystal Structure of the Brca1 BRCT Domains in Complex with the Phosphorylated Interacting Region from Bach1 Helicase\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"1t29\",\n"
+ + " \"resolution\":2.3,\n"
+ + " \"title\":\"Crystal structure of the BRCA1 BRCT repeats bound to a phosphorylated BACH1 peptide\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"Solution NMR\"],\n"
+ + " \"pdb_id\":\"1jm7\",\n"
+ + " \"title\":\"Solution structure of the BRCA1/BARD1 RING-domain heterodimer\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"1t2v\",\n"
+ + " \"resolution\":3.3,\n"
+ + " \"title\":\"Structural basis of phospho-peptide recognition by the BRCT domain of BRCA1, structure with phosphopeptide\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"4ifi\",\n"
+ + " \"resolution\":2.2,\n"
+ + " \"title\":\"Structure of human BRCA1 BRCT in complex with BAAT peptide\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"4igk\",\n"
+ + " \"resolution\":1.75,\n"
+ + " \"title\":\"Structure of human BRCA1 BRCT in complex with ATRIP peptide\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"3k0k\",\n"
+ + " \"resolution\":2.7,\n"
+ + " \"title\":\"Crystal Structure of BRCA1 BRCT in complex with a minimal recognition tetrapeptide with a free carboxy C-terminus.\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"3k16\",\n"
+ + " \"resolution\":3.0,\n"
+ + " \"title\":\"Crystal Structure of BRCA1 BRCT D1840T in complex with a minimal recognition tetrapeptide with a free carboxy C-terminus\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"3k15\",\n"
+ + " \"resolution\":2.8,\n"
+ + " \"title\":\"Crystal Structure of BRCA1 BRCT D1840T in complex with a minimal recognition tetrapeptide with an amidated C-terminus\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"3k0h\",\n"
+ + " \"resolution\":2.7,\n"
+ + " \"title\":\"The crystal structure of BRCA1 BRCT in complex with a minimal recognition tetrapeptide with an amidated C-terminus\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"1y98\",\n"
+ + " \"resolution\":2.5,\n"
+ + " \"title\":\"Structure of the BRCT repeats of BRCA1 bound to a CtIP phosphopeptide.\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"3coj\",\n"
+ + " \"resolution\":3.21,\n"
+ + " \"title\":\"Crystal Structure of the BRCT Domains of Human BRCA1 in Complex with a Phosphorylated Peptide from Human Acetyl-CoA Carboxylase 1\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"X-ray diffraction\"],\n"
+ + " \"pdb_id\":\"4y18\",\n"
+ + " \"resolution\":3.5,\n"
+ + " \"title\":\"Structure of BRCA1 BRCT domains in complex with Abraxas double phosphorylated peptide\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"Electron Microscopy\"],\n"
+ + " \"pdb_id\":\"7jzv\",\n"
+ + " \"resolution\":3.9,\n"
+ + " \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"Electron Microscopy\"],\n"
+ + " \"pdb_id\":\"7jzv\",\n"
+ + " \"resolution\":3.9,\n"
+ + " \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"Electron Microscopy\"],\n"
+ + " \"pdb_id\":\"7lyb\",\n"
+ + " \"resolution\":3.28,\n"
+ + " \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"Electron Microscopy\"],\n"
+ + " \"pdb_id\":\"7lyb\",\n"
+ + " \"resolution\":3.28,\n"
+ + " \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"Electron Microscopy\"],\n"
+ + " \"pdb_id\":\"7lyb\",\n"
+ + " \"resolution\":3.28,\n"
+ + " \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"Electron Microscopy\"],\n"
+ + " \"pdb_id\":\"7jzv\",\n"
+ + " \"resolution\":3.9,\n"
+ + " \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"Electron Microscopy\"],\n"
+ + " \"pdb_id\":\"7lyb\",\n"
+ + " \"resolution\":3.28,\n"
+ + " \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"Electron Microscopy\"],\n"
+ + " \"pdb_id\":\"7jzv\",\n"
+ + " \"resolution\":3.9,\n"
+ + " \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"Electron Microscopy\"],\n"
+ + " \"pdb_id\":\"7lyb\",\n"
+ + " \"resolution\":3.28,\n"
+ + " \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"Electron Microscopy\"],\n"
+ + " \"pdb_id\":\"7jzv\",\n"
+ + " \"resolution\":3.9,\n"
+ + " \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"Electron Microscopy\"],\n"
+ + " \"pdb_id\":\"7lyb\",\n"
+ + " \"resolution\":3.28,\n"
+ + " \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"Electron Microscopy\"],\n"
+ + " \"pdb_id\":\"7lyb\",\n"
+ + " \"resolution\":3.28,\n"
+ + " \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"Electron Microscopy\"],\n"
+ + " \"pdb_id\":\"7lyb\",\n"
+ + " \"resolution\":3.28,\n"
+ + " \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"Electron Microscopy\"],\n"
+ + " \"pdb_id\":\"7jzv\",\n"
+ + " \"resolution\":3.9,\n"
+ + " \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"Electron Microscopy\"],\n"
+ + " \"pdb_id\":\"6g2i\",\n"
+ + " \"resolution\":5.9,\n"
+ + " \"title\":\"Filament of acetyl-CoA carboxylase and BRCT domains of BRCA1 (ACC-BRCT) at 5.9 A resolution\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"Electron Microscopy\"],\n"
+ + " \"pdb_id\":\"7jzv\",\n"
+ + " \"resolution\":3.9,\n"
+ + " \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"Electron Microscopy\"],\n"
+ + " \"pdb_id\":\"7lyb\",\n"
+ + " \"resolution\":3.28,\n"
+ + " \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
+ + " {\n"
+ + " \"experimental_method\":[\"Electron Microscopy\"],\n"
+ + " \"pdb_id\":\"7jzv\",\n"
+ + " \"resolution\":3.9,\n"
+ + " \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"}]\n"
+ + " }}" };
mocks[1] = new String[2];
try {
{
"responseHeader":{
"status":0,
- "QTime":6,
+ "QTime":4,
"params":{
- "q":"(3w7y OR 3w7y OR 5e7w OR 5e7w OR 5hqi OR 5hqi OR 1mso OR 1mso OR 3hyd OR 6ver OR 6ver OR 4fka OR 4fka OR 3tt8 OR 3tt8 OR 3w7z OR 3w7z OR 5usp OR 5usp OR 5uoz OR 5uoz OR 5urt OR 5urt OR 1g7a OR 4ajx OR 1g7a OR 4ajx OR 5uu2 OR 5uu2 OR 6gv0 OR 6gv0 OR 5hrq OR 5hrq OR 1g7b OR 5usv OR 3bxq OR 1g7b OR 5usv OR 3bxq OR 5uqa OR 5uqa OR 5hpr OR 5hpr OR 5udp OR 5udp OR 3fq9 OR 5ena OR 3exx OR 6s34 OR 5ena OR 3exx OR 6s34 OR 3fq9 OR 6tc2 OR 2omh OR 2omh OR 4nib OR 4cy7 OR 3w80 OR 1ben OR 7nhu OR 4nib OR 4cy7 OR 7nhu OR 3w80 OR 1ben OR 6vet OR 6vet OR 4ey1 OR 4ey9 OR 4eyd OR 4ey1 OR 4ey9 OR 4eyd OR 4xc4 OR 4xc4 OR 1zeh OR 2wrx OR 2ws6 OR 2ws6 OR 4cxl OR 5en9 OR 4p65 OR 2c8r OR 6s4j OR 1zeh OR 2wrx OR 2ws6 OR 2c8r OR 4cxl OR 5en9 OR 4p65 OR 6s4j OR 6s4i OR 6s4i OR 2omg OR 2omg OR 4eyn OR 4eyn OR 5bqq OR 5bqq OR 4exx OR 5t7r OR 4exx OR 5t7r OR 2wru OR 2wru OR 6o17 OR 6o17 OR 4une OR 4une OR 4eyp OR 4f1b OR 4eyp OR 4f1b OR 1zeg OR 2ws1 OR 3zu1 OR 1trz OR 4iuz OR 3i3z OR 1uz9 OR 3e7y OR 3i3z OR 1zeg OR 2ws1 OR 1uz9 OR 3zu1 OR 3e7y OR 1trz OR 4iuz OR 6tyh OR 6tyh OR 6nwv OR 6nwv OR 1guj OR 1guj OR 4f1d OR 4f1g OR 4f4t OR 4f4v OR 4f51 OR 4f1d OR 4f1g OR 4f4t OR 4f4v OR 4f51 OR 4ex1 OR 4ex1 OR 4iyd OR 4iyd OR 3utq OR 4f0o OR 4f0o OR 4f8f OR 4f8f OR 4f0n OR 4f0n OR 5c0d OR 4f1f OR 4f1f OR 3zi3 OR 4f1c OR 4cxn OR 5cny OR 5co2 OR 2oly OR 2olz OR 5boq OR 5viz OR 3e7z OR 3zi3 OR 4f1c OR 4cxn OR 5cny OR 3e7z OR 5co2 OR 2oly OR 2olz OR 5boq OR 5viz OR 4rxw OR 4rxw OR 5bts OR 5bts OR 4gbc OR 4gbc OR 1ev3 OR 1ev3 OR 4ewz OR 4ewz OR 4f1a OR 2vjz OR 1rwe OR 5co6 OR 6p4z OR 1xda OR 4ajz OR 4iyf OR 2ceu OR 4f1a OR 2ceu OR 2vjz OR 1rwe OR 1xda OR 5co6 OR 4ajz OR 6p4z OR 4iyf OR 4ung OR 4ung OR 6h3m OR 6h3m OR 3inc OR 3i40 OR 6ves OR 3i40 OR 6ves OR 3inc OR 4z77 OR 4ex0 OR 4ex0 OR 4gbn OR 4gbn OR 5mt9 OR 5mt9 OR 4z76 OR 3ilg OR 3zqr OR 3kq6 OR 1ev6 OR 1evr OR 1tyl OR 1tym OR 5bpo OR 1htv OR 2ws4 OR 1htv OR 2ws4 OR 3ilg OR 3zqr OR 3kq6 OR 1ev6 OR 1evr OR 1tyl OR 1tym OR 5bpo OR 5co9 OR 5co9 OR 1os3 OR 2c8q OR 2c8q OR 1os3 OR 2om1 OR 3zs2 OR 2om1 OR 3zs2 OR 5uu4 OR 5uu4 OR 3u4n OR 4efx OR 3u4n OR 4efx OR 1q4v OR 3p2x OR 2qiu OR 3v19 OR 1j73 OR 1qiz OR 1znj OR 2r36 OR 2w44 OR 2qiu OR 2r36 OR 1q4v OR 3p2x OR 3v19 OR 1j73 OR 1qiz OR 1znj OR 2w44 OR 2omq OR 4fg3 OR 4fg3 OR 4akj OR 4akj OR 5mt3 OR 5mt3 OR 2om0 OR 3q6e OR 2om0 OR 3q6e OR 5uss OR 5uss OR 1w8p OR 2r35 OR 2r35 OR 1w8p OR 2ws0 OR 2ws0 OR 2wrv OR 2wrv OR 6z7y OR 5mam OR 3v1g OR 2vk0 OR 3ir0 OR 5hpu OR 2g56 OR 6gnq OR 6z7y OR 5mam OR 3v1g OR 2vk0 OR 3ir0 OR 5hpu OR 6gnq OR 4ewx OR 4ewx OR 2omi OR 2omi OR 5uu3 OR 1os4 OR 2g54 OR 6ck2 OR 2r34 OR 2r34 OR 5uu3 OR 1os4 OR 6ck2 OR 4ak0 OR 4ak0 OR 3p33 OR 5ems OR 1qiy OR 1lph OR 3rov OR 4eww OR 1xw7 OR 3p33 OR 5ems OR 1qiy OR 1lph OR 3rov OR 4eww OR 1xw7 OR 4z78 OR 4wdi OR 1qj0 OR 4gbk OR 1qj0 OR 4gbk OR 1jk8 OR 5uru OR 2wrw OR 2wrw OR 5uru OR 6z7w OR 6z7w OR 1jca OR 3jsd OR 1b9e OR 4gbl OR 1jca OR 3jsd OR 1b9e OR 4gbl OR 4y19 OR 4gbi OR 4gbi OR 2ws7 OR 2ws7 OR 2wby OR 2wby OR 3utt OR 3uts OR 4unh OR 4unh OR 2wc0 OR 2wc0 OR 5wdm OR 6vep OR 6vep OR 5hyj OR 6hn5 OR 6hn5 OR 5cjo OR 4oga OR 4oga OR 6b70 OR 6b3q OR 6bfc OR 7bw8 OR 3w11 OR 3w11 OR 5wob OR 4y1a OR 7bw7 OR 6sof OR 6ce9 OR 6sof OR 3w12 OR 3w12 OR 3w13 OR 3w13 OR 6jk8 OR 6ceb OR 7bwa OR 6ce7 OR 6jr3 OR 6jr3 OR 2kqp OR 1efe OR 6u46 OR 1sju OR 5mwq OR 6k59 OR 1t0c OR 5mhd OR 2lgb OR 2mvd OR 2mvc OR 1k3m OR 2juu OR 1hiq OR 2juv OR 2rn5 OR 2kxk OR 2hiu OR 2l1y OR 2l1z OR 2kju OR 1xgl OR 1jco OR 2jv1 OR 2kqq OR 1fu2 OR 1kmf OR 1vkt OR 1fub OR 2n2x OR 2n2v OR 2n2w OR 1t1k OR 1t1p OR 1t1q OR 2mpg OR 1sf1 OR 2mpi OR 2jmn OR 2k9r OR 6x4x OR 1lkq OR 2m1d OR 2m1e OR 2mli OR 2hh4 OR 2m2m OR 2aiy OR 1hit OR 2hho OR 1hls OR 2m2n OR 2m2o OR 2m2p OR 3aiy OR 4aiy OR 5aiy OR 2kjj OR 2k91 OR 1ai0 OR 1aiy OR 2h67 OR 1mhi OR 2jum OR 1sjt OR 1a7f OR 1iog OR 1ioh OR 1mhj OR 1hui OR 1his OR 2mvc OR 2mvd OR 1k3m OR 2juu OR 1hiq OR 2juv OR 2rn5 OR 2kxk OR 2hiu OR 2l1z OR 2l1y OR 1sjt OR 2kju OR 1xgl OR 1jco OR 2jv1 OR 1a7f OR 1iog OR 1ioh OR 2kqq OR 1fu2 OR 1kmf OR 1vkt OR 1fub OR 2n2v OR 2n2w OR 2n2x OR 1t1k OR 1t1p OR 1t1q OR 2mpg OR 1sf1 OR 5mwq OR 2mpi OR 2jmn OR 2k9r OR 6x4x OR 5mhd OR 1lkq OR 2lgb OR 2m1d OR 2m1e OR 2mli OR 2hh4 OR 2m2m OR 2aiy OR 1his OR 1hit OR 2hho OR 1hls OR 2m2n OR 2m2o OR 2m2p OR 3aiy OR 4aiy OR 5aiy OR 1hui OR 2kjj OR 2k91 OR 1ai0 OR 1aiy OR 2h67 OR 1mhi OR 1mhj OR 2jum OR 6k59) AND molecule_sequence:['' TO *] AND status:REL",
+ "q":"(5hpu OR 2jmn OR 4iuz OR 6s34 OR 1efe OR 6ce7 OR 1w8p OR 1evr OR 1hls OR 5hpr OR 7jp3 OR 3v19 OR 5bts OR 3q6e OR 2m1d OR 2m1e OR 2n2v OR 2n2w OR 2n2x OR 1t1p OR 1t1q OR 2rn5 OR 2m2o OR 4une OR 3v1g OR 2m2p OR 4unh OR 5t7r OR 4ung OR 4gbi OR 4rxw OR 4gbl OR 4gbk OR 4gbn OR 3aiy OR 1ioh OR 1iog OR 5wob OR 4gbc OR 2m2m OR 2m2n OR 5hqi OR 2hiu OR 6ce9 OR 4z76 OR 4z78 OR 4z77 OR 2kqp OR 2kqq OR 5en9 OR 6k59 OR 1mhj OR 1mhi OR 5hrq OR 6ceb OR 1jca OR 4p65 OR 1k3m OR 3kq6 OR 6s4i OR 4f0o OR 6s4j OR 4f0n OR 6gnq OR 5ems OR 2mvc OR 2mvd OR 1sf1 OR 3hyd OR 2l1y OR 1uz9 OR 2l1z OR 7nhu OR 3w80 OR 4aiy OR 3utq OR 3ilg OR 5cjo OR 4ak0 OR 6b3q OR 4f1g OR 4wdi OR 1jco OR 1vkt OR 6tyh OR 4iyd OR 5ena OR 4f1b OR 4f1a OR 4iyf OR 4f1d OR 4f1c OR 4f1f OR 4ajx OR 4ajz OR 1ben OR 1tyl OR 1tym OR 2vk0 OR 6bfc OR 2om0 OR 2om1 OR 3uts OR 3utt OR 3tt8 OR 2omh OR 2omi OR 3u4n OR 6o17 OR 4fg3 OR 2vjz OR 4oga OR 2lgb OR 6ck2 OR 2omg OR 5uoz OR 2oly OR 1zeg OR 2olz OR 3inc OR 1zeh OR 4akj OR 4f51 OR 3w7y OR 3rov OR 3w7z OR 6b70 OR 5co9 OR 1j73 OR 5aiy OR 5co2 OR 1os4 OR 5uqa OR 1os3 OR 4f4t OR 2jv1 OR 5co6 OR 4f4v OR 7bw7 OR 5wdm OR 7bw8 OR 1rwe OR 2ceu OR 2omq OR 2r34 OR 2r35 OR 7s4y OR 2r36 OR 5cny OR 2juu OR 2juv OR 5mt9 OR 2jum OR 3exx OR 3ir0 OR 1htv OR 5mt3 OR 7bwa OR 3zqr OR 6h3m OR 1lkq OR 5mam OR 3zs2 OR 2mli OR 1ai0 OR 5usp OR 5uu2 OR 5uu4 OR 5uu3 OR 3e7y OR 3e7z OR 4ex0 OR 3jsd OR 6gv0 OR 4ex1 OR 2kxk OR 1sjt OR 1q4v OR 1sju OR 5uru OR 5urt OR 6jk8 OR 1xda OR 6z7y OR 1hui OR 5hyj OR 6z7w OR 4ey9 OR 4eww OR 1a7f OR 2k91 OR 4nib OR 1b9e OR 4ewx OR 4ewz OR 4ey1 OR 1jk8 OR 5uss OR 5usv OR 3zu1 OR 6p4z OR 4efx OR 6x4x OR 1xw7 OR 2kjj OR 1kmf OR 4eyd OR 1fu2 OR 4exx OR 2wc0 OR 2ws6 OR 1qj0 OR 2ws7 OR 2c8q OR 2c8r OR 5udp OR 5boq OR 4f8f OR 2ws0 OR 2ws1 OR 1guj OR 2ws4 OR 1lph OR 2wby OR 1qiz OR 1qiy OR 3i40 OR 2k9r OR 6sof OR 2wru OR 4fka OR 4eyp OR 2wrv OR 2wrw OR 2wrx OR 1xgl OR 5bpo OR 1aiy OR 5c0d OR 2kju OR 4eyn OR 3fq9 OR 3i3z OR 3p33 OR 1hiq OR 2mpg OR 5mwq OR 2mpi OR 1mso OR 2h67 OR 6vep OR 5bqq OR 6ves OR 4y19 OR 6vet OR 1fub OR 6ver OR 6tc2 OR 1t0c OR 1ev6 OR 1ev3 OR 2aiy OR 3zi3 OR 5viz OR 2g54 OR 4y1a OR 6nwv OR 5mhd OR 2g56 OR 3bxq OR 4cy7 OR 1hit OR 1his OR 2hh4 OR 6u46 OR 3w11 OR 2w44 OR 3w12 OR 3w13 OR 6hn5 OR 2hho OR 5e7w OR 1t1k OR 4xc4 OR 6jr3 OR 1trz OR 2qiu OR 1g7b OR 1g7a OR 4cxl OR 3p2x OR 4cxn OR 1znj) AND molecule_sequence:['' TO *] AND status:REL",
"fl":"pdb_id,title,experimental_method,resolution",
"start":"0",
"sort":"",
"rows":"500",
"wt":"json"}},
- "response":{"numFound":638,"start":0,"docs":[
+ "response":{"numFound":641,"start":0,"docs":[
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2ws6",
- "resolution":1.5,
- "title":"Semi-synthetic analogue of human insulin NMeTyrB26-insulin in hexamer form"},
+ "pdb_id":"3hyd",
+ "resolution":1.0,
+ "title":"LVEALYL peptide derived from human insulin chain B, residues 11-17"},
{
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"2ws6",
- "resolution":1.5,
- "title":"Semi-synthetic analogue of human insulin NMeTyrB26-insulin in hexamer form"},
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"1t0c",
+ "title":"Solution Structure of Human Proinsulin C-Peptide"},
+ {
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"6u46",
+ "title":"Solution Structure of a Heat-Resistant Long-Acting Insulin Analog"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2ws6",
- "resolution":1.5,
- "title":"Semi-synthetic analogue of human insulin NMeTyrB26-insulin in hexamer form"},
+ "pdb_id":"2omq",
+ "resolution":2.0,
+ "title":"VEALYL peptide derived from human insulin chain B, residues 12-17"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"1hit",
- "title":"Receptor binding redefined by a structural switch in a mutant Human Insulin"},
+ "pdb_id":"1sju",
+ "title":"MINI-PROINSULIN, SINGLE CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP AND PEPTIDE BOND BETWEEN LYS B 29 AND GLY A 1, NMR, 20 STRUCTURES"},
+ {
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"1efe",
+ "title":"AN ACTIVE MINI-PROINSULIN, M2PI"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"5wdm",
+ "resolution":2.803,
+ "title":"An ultra-stable single-chain insulin analog resists thermal inactivation and exhibits biological signaling duration equivalent to the native protein"},
{
"experimental_method":["Solution NMR"],
"pdb_id":"1his",
"title":"Receptor binding redefined by a structural switch in a mutant Human Insulin"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2m2o",
- "title":"Structure of [D-HisB24] insulin analogue at pH 1.9"},
+ "pdb_id":"1hit",
+ "title":"Receptor binding redefined by a structural switch in a mutant Human Insulin"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2m1d",
- "title":"Biosynthetic engineered B28K-B29P human insulin monomer structure in in water/acetonitrile solutions."},
+ "pdb_id":"1vkt",
+ "title":"HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2m2n",
- "title":"Structure of [L-HisB24] insulin analogue at pH 8.0"},
+ "pdb_id":"2m1e",
+ "title":"Biosynthetic engineered B28K-B29P human insulin monomer structure in in water solutions."},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2m2n",
- "title":"Structure of [L-HisB24] insulin analogue at pH 8.0"},
+ "pdb_id":"2m2o",
+ "title":"Structure of [D-HisB24] insulin analogue at pH 1.9"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"1sjt",
- "title":"MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP, NMR, 20 STRUCTURES"},
+ "pdb_id":"2m2p",
+ "title":"Structure of [D-HisB24] insulin analogue at pH 8.0"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"1vkt",
- "title":"HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES"},
+ "pdb_id":"2m1d",
+ "title":"Biosynthetic engineered B28K-B29P human insulin monomer structure in in water/acetonitrile solutions."},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"2c8q",
+ "resolution":1.95,
+ "title":"insuline(1sec) and UV laser excited fluorescence"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"2c8q",
+ "resolution":1.95,
+ "title":"insuline(1sec) and UV laser excited fluorescence"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"2c8r",
"title":"PARADOXICAL STRUCTURE AND FUNCTION IN A MUTANT HUMAN INSULIN ASSOCIATED WITH DIABETES MELLITUS"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2c8q",
- "resolution":1.95,
- "title":"insuline(1sec) and UV laser excited fluorescence"},
+ "pdb_id":"7nhu",
+ "resolution":1.4,
+ "title":"Crystal structure of desB30 insulin produced by cell free protein synthesis"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2c8q",
- "resolution":1.95,
- "title":"insuline(1sec) and UV laser excited fluorescence"},
+ "pdb_id":"7nhu",
+ "resolution":1.4,
+ "title":"Crystal structure of desB30 insulin produced by cell free protein synthesis"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"6o17",
"resolution":1.58,
"title":"Recombinant Human Insulin"},
{
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"7nhu",
- "resolution":1.4,
- "title":"Crystal structure of desB30 insulin produced by cell free protein synthesis"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"7nhu",
- "resolution":1.4,
- "title":"Crystal structure of desB30 insulin produced by cell free protein synthesis"},
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"2mvc",
+ "title":"Solution structure of human insulin at pH 1.9"},
{
"experimental_method":["Solution NMR"],
"pdb_id":"2mvd",
"title":"Solution structure of [GlnB22]-insulin mutant at pH 1.9"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2mvc",
- "title":"Solution structure of human insulin at pH 1.9"},
+ "pdb_id":"2m2n",
+ "title":"Structure of [L-HisB24] insulin analogue at pH 8.0"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2m1e",
- "title":"Biosynthetic engineered B28K-B29P human insulin monomer structure in in water solutions."},
+ "pdb_id":"2m2n",
+ "title":"Structure of [L-HisB24] insulin analogue at pH 8.0"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2m2p",
- "title":"Structure of [D-HisB24] insulin analogue at pH 8.0"},
+ "pdb_id":"1vkt",
+ "title":"HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"2ws4",
"title":"Semi-synthetic analogue of human insulin ProB26-DTI in monomer form"},
{
"experimental_method":["Solution NMR"],
+ "pdb_id":"2m1e",
+ "title":"Biosynthetic engineered B28K-B29P human insulin monomer structure in in water solutions."},
+ {
+ "experimental_method":["Solution NMR"],
"pdb_id":"2m2o",
"title":"Structure of [D-HisB24] insulin analogue at pH 1.9"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2m1d",
- "title":"Biosynthetic engineered B28K-B29P human insulin monomer structure in in water/acetonitrile solutions."},
+ "pdb_id":"2m2p",
+ "title":"Structure of [D-HisB24] insulin analogue at pH 8.0"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2m1e",
- "title":"Biosynthetic engineered B28K-B29P human insulin monomer structure in in water solutions."},
+ "pdb_id":"2m1d",
+ "title":"Biosynthetic engineered B28K-B29P human insulin monomer structure in in water/acetonitrile solutions."},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"1sjt",
- "title":"MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP, NMR, 20 STRUCTURES"},
+ "pdb_id":"1k3m",
+ "title":"NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALA, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"1vkt",
- "title":"HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"3ilg",
- "resolution":1.9,
- "title":"Crystal structure of humnan insulin Sr+2 complex"},
+ "pdb_id":"1k3m",
+ "title":"NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALA, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES"},
{
"experimental_method":["Solution NMR"],
"pdb_id":"1lkq",
"title":"NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-GLY, VAL-A3-GLY, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 20 STRUCTURES"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"1k3m",
- "title":"NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALA, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES"},
+ "pdb_id":"1sjt",
+ "title":"MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP, NMR, 20 STRUCTURES"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"1k3m",
- "title":"NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALA, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES"},
+ "pdb_id":"1sjt",
+ "title":"MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP, NMR, 20 STRUCTURES"},
{
"experimental_method":["Solution NMR"],
"pdb_id":"1lkq",
"title":"NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-GLY, VAL-A3-GLY, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 20 STRUCTURES"},
{
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"3ilg",
+ "resolution":1.9,
+ "title":"Crystal structure of humnan insulin Sr+2 complex"},
+ {
"experimental_method":["Solution NMR"],
"pdb_id":"5mwq",
"title":"Biosynthetic engineered A21K-B31K-B32R human insulin monomer structure in water/acetonitrile solution"},
{
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"2mvc",
+ "title":"Solution structure of human insulin at pH 1.9"},
+ {
"experimental_method":["X-ray diffraction"],
"pdb_id":"5ena",
"resolution":1.35,
"resolution":1.7,
"title":"X-Ray structure of Insulin Glargine"},
{
- "experimental_method":["Solution NMR"],
- "pdb_id":"2mvc",
- "title":"Solution structure of human insulin at pH 1.9"},
- {
"experimental_method":["X-ray diffraction"],
"pdb_id":"5en9",
"resolution":1.5,
"title":"High resolution x-ray crystal structure of isotope-labeled ester-insulin"},
{
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"3i40",
+ "resolution":1.85,
+ "title":"Human insulin"},
+ {
"experimental_method":["Solution NMR"],
- "pdb_id":"2m2p",
- "title":"Structure of [D-HisB24] insulin analogue at pH 8.0"},
+ "pdb_id":"2kjj",
+ "title":"Dynamics of insulin probed by 1H-NMR amide proton exchange anomalous flexibility of the receptor-binding surface"},
+ {
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"2kjj",
+ "title":"Dynamics of insulin probed by 1H-NMR amide proton exchange anomalous flexibility of the receptor-binding surface"},
+ {
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"2juu",
+ "title":"allo-ThrA3 DKP-insulin"},
{
"experimental_method":["Solution NMR"],
"pdb_id":"2jum",
"title":"ThrA3-DKP-insulin"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2kjj",
- "title":"Dynamics of insulin probed by 1H-NMR amide proton exchange anomalous flexibility of the receptor-binding surface"},
+ "pdb_id":"2jv1",
+ "title":"NMR structure of human insulin monomer in 35% CD3CN zinc free, 50 structures"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2kjj",
- "title":"Dynamics of insulin probed by 1H-NMR amide proton exchange anomalous flexibility of the receptor-binding surface"},
+ "pdb_id":"1iog",
+ "title":"INSULIN MUTANT A3 GLY,(B1, B10, B16, B27)GLU, DES-B30, NMR, 19 STRUCTURES"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2jv1",
- "title":"NMR structure of human insulin monomer in 35% CD3CN zinc free, 50 structures"},
+ "pdb_id":"1jco",
+ "title":"Solution structure of the monomeric [Thr(B27)->Pro,Pro(B28)->Thr] insulin mutant (PT insulin)"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2kju",
- "title":"NMR structure of human insulin mutant glu-b21-d-glu, his-b10 asp pro-b28-lys, lys-b29-pro, 20 structures"},
+ "pdb_id":"1xgl",
+ "title":"HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2juu",
- "title":"allo-ThrA3 DKP-insulin"},
+ "pdb_id":"1xgl",
+ "title":"HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2wrw",
- "resolution":2.41,
- "title":"Semi-synthetic highly active analogue of human insulin D-ProB26-DTI- NH2"},
+ "pdb_id":"2r35",
+ "resolution":2.08,
+ "title":"Crystal structure of RB human arg-insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2wrw",
- "resolution":2.41,
- "title":"Semi-synthetic highly active analogue of human insulin D-ProB26-DTI- NH2"},
+ "pdb_id":"2qiu",
+ "resolution":2.0,
+ "title":"Structure of Human Arg-Insulin"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"2ws4",
"title":"Semi-synthetic analogue of human insulin ProB26-DTI in monomer form"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2r34",
- "resolution":2.25,
- "title":"Crystal structure of MN human arg-insulin"},
+ "pdb_id":"2wrw",
+ "resolution":2.41,
+ "title":"Semi-synthetic highly active analogue of human insulin D-ProB26-DTI- NH2"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"2wrw",
+ "resolution":2.41,
+ "title":"Semi-synthetic highly active analogue of human insulin D-ProB26-DTI- NH2"},
{
"experimental_method":["Solution NMR"],
"pdb_id":"2l1z",
"title":"NMR Structure of human insulin mutant GLY-B20-D-ALA, GLY-B23-D-ALA PRO-B28-LYS, LYS-B29-PRO, 20 Structures"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2qiu",
- "resolution":2.0,
- "title":"Structure of Human Arg-Insulin"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"1os4",
+ "pdb_id":"2r34",
"resolution":2.25,
- "title":"Dehydrated T6 human insulin at 295 K"},
- {
- "experimental_method":["Solution NMR"],
- "pdb_id":"1t1k",
- "title":"NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ALA, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES"},
- {
- "experimental_method":["Solution NMR"],
- "pdb_id":"1t1k",
- "title":"NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ALA, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"3ilg",
- "resolution":1.9,
- "title":"Crystal structure of humnan insulin Sr+2 complex"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"3i40",
- "resolution":1.85,
- "title":"Human insulin"},
- {
- "experimental_method":["Solution NMR"],
- "pdb_id":"1xgl",
- "title":"HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES"},
- {
- "experimental_method":["Solution NMR"],
- "pdb_id":"1xgl",
- "title":"HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES"},
- {
- "experimental_method":["Solution NMR"],
- "pdb_id":"1iog",
- "title":"INSULIN MUTANT A3 GLY,(B1, B10, B16, B27)GLU, DES-B30, NMR, 19 STRUCTURES"},
- {
- "experimental_method":["Solution NMR"],
- "pdb_id":"1jco",
- "title":"Solution structure of the monomeric [Thr(B27)->Pro,Pro(B28)->Thr] insulin mutant (PT insulin)"},
+ "title":"Crystal structure of MN human arg-insulin"},
{
"experimental_method":["Solution NMR"],
"pdb_id":"1kmf",
"title":"NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALLO-ILE, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES"},
{
"experimental_method":["Solution NMR"],
+ "pdb_id":"1ioh",
+ "title":"INSULIN MUTANT A8 HIS,(B1, B10, B16, B27)GLU, DES-B30, NMR, 26 STRUCTURES"},
+ {
+ "experimental_method":["Solution NMR"],
"pdb_id":"1hui",
"title":"INSULIN MUTANT (B1, B10, B16, B27)GLU, DES-B30, NMR, 25 STRUCTURES"},
{
"pdb_id":"1hui",
"title":"INSULIN MUTANT (B1, B10, B16, B27)GLU, DES-B30, NMR, 25 STRUCTURES"},
{
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"1os4",
+ "resolution":2.25,
+ "title":"Dehydrated T6 human insulin at 295 K"},
+ {
"experimental_method":["Solution NMR"],
"pdb_id":"1a7f",
"title":"INSULIN MUTANT B16 GLU, B24 GLY, DES-B30, NMR, 20 STRUCTURES"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"1ioh",
- "title":"INSULIN MUTANT A8 HIS,(B1, B10, B16, B27)GLU, DES-B30, NMR, 26 STRUCTURES"},
+ "pdb_id":"2kju",
+ "title":"NMR structure of human insulin mutant glu-b21-d-glu, his-b10 asp pro-b28-lys, lys-b29-pro, 20 structures"},
{
- "experimental_method":["Electron Microscopy"],
- "pdb_id":"6jr3",
- "resolution":14.5,
- "title":"Crystal structure of insulin hexamer fitted into cryo EM density map where each dimer was kept as rigid body"},
- {
- "experimental_method":["Electron Microscopy"],
- "pdb_id":"6jr3",
- "resolution":14.5,
- "title":"Crystal structure of insulin hexamer fitted into cryo EM density map where each dimer was kept as rigid body"},
- {
- "experimental_method":["Solution NMR"],
- "pdb_id":"5mwq",
- "title":"Biosynthetic engineered A21K-B31K-B32R human insulin monomer structure in water/acetonitrile solution"},
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"3ilg",
+ "resolution":1.9,
+ "title":"Crystal structure of humnan insulin Sr+2 complex"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"6x4x",
- "title":"B24Y DKP insulin"},
+ "pdb_id":"1t1k",
+ "title":"NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ALA, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"6x4x",
- "title":"B24Y DKP insulin"},
+ "pdb_id":"1t1k",
+ "title":"NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ALA, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"5t7r",
"resolution":1.55,
"title":"A6-A11 trans-dicarba human insulin"},
{
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"5mwq",
+ "title":"Biosynthetic engineered A21K-B31K-B32R human insulin monomer structure in water/acetonitrile solution"},
+ {
+ "experimental_method":["Electron Microscopy"],
+ "pdb_id":"6jr3",
+ "resolution":14.5,
+ "title":"Crystal structure of insulin hexamer fitted into cryo EM density map where each dimer was kept as rigid body"},
+ {
+ "experimental_method":["Electron Microscopy"],
+ "pdb_id":"6jr3",
+ "resolution":14.5,
+ "title":"Crystal structure of insulin hexamer fitted into cryo EM density map where each dimer was kept as rigid body"},
+ {
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"6x4x",
+ "title":"B24Y DKP insulin"},
+ {
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"6x4x",
+ "title":"B24Y DKP insulin"},
+ {
"experimental_method":["X-ray diffraction"],
"pdb_id":"5ena",
"resolution":1.35,
"title":"Xray crystal structure of isotope-labeled human insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"3zi3",
- "resolution":1.7,
- "title":"Crystal structure of the B24His-insulin - human analogue"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"3zi3",
- "resolution":1.7,
- "title":"Crystal structure of the B24His-insulin - human analogue"},
- {
- "experimental_method":["X-ray diffraction"],
"pdb_id":"3u4n",
"resolution":1.98,
"title":"A novel covalently linked insulin dimer"},
"title":"A novel covalently linked insulin dimer"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2r35",
- "resolution":2.08,
- "title":"Crystal structure of RB human arg-insulin"},
+ "pdb_id":"3zi3",
+ "resolution":1.7,
+ "title":"Crystal structure of the B24His-insulin - human analogue"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"3zi3",
+ "resolution":1.7,
+ "title":"Crystal structure of the B24His-insulin - human analogue"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"5en9",
"resolution":1.5,
"title":"High resolution x-ray crystal structure of isotope-labeled ester-insulin"},
{
- "experimental_method":["Solution NMR"],
- "pdb_id":"2h67",
- "title":"NMR structure of human insulin mutant HIS-B5-ALA, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structures"},
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"7jp3",
+ "resolution":1.95,
+ "title":"Des-B29,B30-insulin"},
{
- "experimental_method":["Solution NMR"],
- "pdb_id":"2kju",
- "title":"NMR structure of human insulin mutant glu-b21-d-glu, his-b10 asp pro-b28-lys, lys-b29-pro, 20 structures"},
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"3i40",
+ "resolution":1.85,
+ "title":"Human insulin"},
{
"experimental_method":["Solution NMR"],
"pdb_id":"2hho",
"title":"NMR structure of human insulin mutant GLY-B8-SER, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structures"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2juv",
- "title":"AbaA3-DKP-insulin"},
+ "pdb_id":"2juu",
+ "title":"allo-ThrA3 DKP-insulin"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2juv",
- "title":"AbaA3-DKP-insulin"},
+ "pdb_id":"2h67",
+ "title":"NMR structure of human insulin mutant HIS-B5-ALA, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structures"},
+ {
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"2h67",
+ "title":"NMR structure of human insulin mutant HIS-B5-ALA, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structures"},
{
"experimental_method":["Solution NMR"],
"pdb_id":"2jv1",
"title":"NMR structure of human insulin monomer in 35% CD3CN zinc free, 50 structures"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2juu",
- "title":"allo-ThrA3 DKP-insulin"},
+ "pdb_id":"2juv",
+ "title":"AbaA3-DKP-insulin"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2h67",
- "title":"NMR structure of human insulin mutant HIS-B5-ALA, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structures"},
+ "pdb_id":"2juv",
+ "title":"AbaA3-DKP-insulin"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"2ws0",
"title":"Semi-synthetic analogue of human insulin NMeAlaB26-insulin at pH 7.5"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2rn5",
- "title":"Humal Insulin Mutant B31Lys-B32Arg"},
- {
- "experimental_method":["Solution NMR"],
- "pdb_id":"2rn5",
- "title":"Humal Insulin Mutant B31Lys-B32Arg"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"2qiu",
- "resolution":2.0,
- "title":"Structure of Human Arg-Insulin"},
- {
- "experimental_method":["Solution NMR"],
- "pdb_id":"2lgb",
- "title":"Modified A22Gly-B31Arg Human Insulin"},
+ "pdb_id":"1iog",
+ "title":"INSULIN MUTANT A3 GLY,(B1, B10, B16, B27)GLU, DES-B30, NMR, 19 STRUCTURES"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2lgb",
- "title":"Modified A22Gly-B31Arg Human Insulin"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"1os4",
- "resolution":2.25,
- "title":"Dehydrated T6 human insulin at 295 K"},
+ "pdb_id":"1jco",
+ "title":"Solution structure of the monomeric [Thr(B27)->Pro,Pro(B28)->Thr] insulin mutant (PT insulin)"},
{
"experimental_method":["Solution NMR"],
"pdb_id":"1t1p",
"title":"NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-THR, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2aiy",
- "title":"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES"},
+ "pdb_id":"1t1q",
+ "title":"NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ABA, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES"},
+ {
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"1t1q",
+ "title":"NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ABA, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES"},
{
"experimental_method":["Solution NMR"],
"pdb_id":"1sf1",
"pdb_id":"1sf1",
"title":"NMR STRUCTURE OF HUMAN INSULIN under Amyloidogenic Condition, 15 STRUCTURES"},
{
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"2r35",
+ "resolution":2.08,
+ "title":"Crystal structure of RB human arg-insulin"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"2qiu",
+ "resolution":2.0,
+ "title":"Structure of Human Arg-Insulin"},
+ {
"experimental_method":["Solution NMR"],
- "pdb_id":"1t1q",
- "title":"NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ABA, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES"},
+ "pdb_id":"2rn5",
+ "title":"Humal Insulin Mutant B31Lys-B32Arg"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"1t1q",
- "title":"NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ABA, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES"},
+ "pdb_id":"2rn5",
+ "title":"Humal Insulin Mutant B31Lys-B32Arg"},
{
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"3i3z",
- "resolution":1.6,
- "title":"Human insulin"},
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"2lgb",
+ "title":"Modified A22Gly-B31Arg Human Insulin"},
{
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"3i3z",
- "resolution":1.6,
- "title":"Human insulin"},
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"2lgb",
+ "title":"Modified A22Gly-B31Arg Human Insulin"},
{
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"3i40",
- "resolution":1.85,
- "title":"Human insulin"},
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"1ioh",
+ "title":"INSULIN MUTANT A8 HIS,(B1, B10, B16, B27)GLU, DES-B30, NMR, 26 STRUCTURES"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"1iog",
- "title":"INSULIN MUTANT A3 GLY,(B1, B10, B16, B27)GLU, DES-B30, NMR, 19 STRUCTURES"},
+ "pdb_id":"1a7f",
+ "title":"INSULIN MUTANT B16 GLU, B24 GLY, DES-B30, NMR, 20 STRUCTURES"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"1mso",
"resolution":1.0,
"title":"T6 Human Insulin at 1.0 A Resolution"},
{
- "experimental_method":["Solution NMR"],
- "pdb_id":"1jco",
- "title":"Solution structure of the monomeric [Thr(B27)->Pro,Pro(B28)->Thr] insulin mutant (PT insulin)"},
- {
- "experimental_method":["Solution NMR"],
- "pdb_id":"1a7f",
- "title":"INSULIN MUTANT B16 GLU, B24 GLY, DES-B30, NMR, 20 STRUCTURES"},
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"1os4",
+ "resolution":2.25,
+ "title":"Dehydrated T6 human insulin at 295 K"},
{
"experimental_method":["Solution NMR"],
"pdb_id":"1hls",
"pdb_id":"1hls",
"title":"NMR STRUCTURE OF THE HUMAN INSULIN-HIS(B16)"},
{
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"3i3z",
+ "resolution":1.6,
+ "title":"Human insulin"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"3i3z",
+ "resolution":1.6,
+ "title":"Human insulin"},
+ {
"experimental_method":["Solution NMR"],
- "pdb_id":"1ioh",
- "title":"INSULIN MUTANT A8 HIS,(B1, B10, B16, B27)GLU, DES-B30, NMR, 26 STRUCTURES"},
+ "pdb_id":"2kju",
+ "title":"NMR structure of human insulin mutant glu-b21-d-glu, his-b10 asp pro-b28-lys, lys-b29-pro, 20 structures"},
+ {
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"2aiy",
+ "title":"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4iyd",
- "resolution":1.66,
- "title":"Insulin glargine crystal structure 1"},
+ "pdb_id":"6ves",
+ "resolution":1.85,
+ "title":"Human insulin analog: [GluB10,HisA8,ArgA9]-DOI"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4iyd",
- "resolution":1.66,
- "title":"Insulin glargine crystal structure 1"},
+ "pdb_id":"6ves",
+ "resolution":1.85,
+ "title":"Human insulin analog: [GluB10,HisA8,ArgA9]-DOI"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"6s34",
"title":"Zinc free, dimeric human insulin determined to 1.35 Angstrom resolution"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"6ves",
- "resolution":1.85,
- "title":"Human insulin analog: [GluB10,HisA8,ArgA9]-DOI"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"6ves",
- "resolution":1.85,
- "title":"Human insulin analog: [GluB10,HisA8,ArgA9]-DOI"},
+ "pdb_id":"4ung",
+ "resolution":1.81,
+ "title":"Human insulin B26Asn mutant crystal structure"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"4unh",
"title":"Solution structure of the [AibB8,LysB28,ProB29]-insulin analogue"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"3w7y",
- "resolution":0.92,
- "title":"0.92A structure of 2Zn human insulin at 100K"},
+ "pdb_id":"4iyd",
+ "resolution":1.66,
+ "title":"Insulin glargine crystal structure 1"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"3w7y",
- "resolution":0.92,
- "title":"0.92A structure of 2Zn human insulin at 100K"},
+ "pdb_id":"4iyd",
+ "resolution":1.66,
+ "title":"Insulin glargine crystal structure 1"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"3w7z",
"title":"1.15A structure of human 2Zn insulin at 293K"},
{
"experimental_method":["X-ray diffraction"],
+ "pdb_id":"3w7y",
+ "resolution":0.92,
+ "title":"0.92A structure of 2Zn human insulin at 100K"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"3w7y",
+ "resolution":0.92,
+ "title":"0.92A structure of 2Zn human insulin at 100K"},
+ {
+ "experimental_method":["X-ray diffraction"],
"pdb_id":"4ak0",
"resolution":2.28,
"title":"Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engineered acylated insulin"},
"resolution":1.1746387,
"title":"Insulin with proline analog FyP at position B28 in the T2 state"},
{
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"4ung",
- "resolution":1.81,
- "title":"Human insulin B26Asn mutant crystal structure"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"2r35",
- "resolution":2.08,
- "title":"Crystal structure of RB human arg-insulin"},
- {
"experimental_method":["Solution NMR"],
"pdb_id":"2hiu",
"title":"NMR STRUCTURE OF HUMAN INSULIN IN 20% ACETIC ACID, ZINC-FREE, 10 STRUCTURES"},
"pdb_id":"2m2m",
"title":"Structure of [L-HisB24] insulin analogue at pH 1.9"},
{
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"2wrx",
- "resolution":1.5,
- "title":"Semi-synthetic analogue of human insulin NMeAlaB26-insulin at pH 3.0"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"2wrx",
- "resolution":1.5,
- "title":"Semi-synthetic analogue of human insulin NMeAlaB26-insulin at pH 3.0"},
- {
"experimental_method":["Solution NMR"],
"pdb_id":"2hho",
"title":"NMR structure of human insulin mutant GLY-B8-SER, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structures"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2hh4",
- "title":"NMR structure of human insulin mutant GLY-B8-D-SER, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structures"},
+ "pdb_id":"2k91",
+ "title":"Enhancing the activity of insulin by stereospecific unfolding"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2hh4",
- "title":"NMR structure of human insulin mutant GLY-B8-D-SER, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structures"},
+ "pdb_id":"2k91",
+ "title":"Enhancing the activity of insulin by stereospecific unfolding"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2kxk",
- "title":"Human Insulin Mutant A22Gly-B31Lys-B32Arg"},
+ "pdb_id":"2hh4",
+ "title":"NMR structure of human insulin mutant GLY-B8-D-SER, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structures"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2kxk",
- "title":"Human Insulin Mutant A22Gly-B31Lys-B32Arg"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"4cxn",
- "resolution":1.7,
- "title":"Crystal structure of human insulin analogue (NMe-AlaB8)-insulin crystal form I"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"4cxn",
- "resolution":1.7,
- "title":"Crystal structure of human insulin analogue (NMe-AlaB8)-insulin crystal form I"},
+ "pdb_id":"2hh4",
+ "title":"NMR structure of human insulin mutant GLY-B8-D-SER, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structures"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"2ws0",
"resolution":2.1,
"title":"Semi-synthetic analogue of human insulin NMeAlaB26-insulin at pH 7.5"},
{
- "experimental_method":["Solution NMR"],
- "pdb_id":"2kqq",
- "title":"NMR structure of human insulin mutant gly-b8-d-ala, his-b10-asp, pro-b28-lys, lys-b29-pro, 20 structures"},
- {
- "experimental_method":["Solution NMR"],
- "pdb_id":"2l1y",
- "title":"NMR Structure of human insulin mutant GLY-B20-D-ALA, GLY-B23-D-ALA PRO-B28-LYS, LYS-B29-PRO, 20 Structures"},
- {
"experimental_method":["X-ray diffraction"],
"pdb_id":"1os3",
"resolution":1.95,
"pdb_id":"3aiy",
"title":"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, REFINED AVERAGE STRUCTURE"},
{
- "experimental_method":["Solution NMR"],
- "pdb_id":"2aiy",
- "title":"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES"},
- {
"experimental_method":["X-ray diffraction"],
"pdb_id":"3inc",
"resolution":1.85,
"resolution":1.85,
"title":"Crystal structure of human insulin with Ni+2 complex"},
{
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"2kxk",
+ "title":"Human Insulin Mutant A22Gly-B31Lys-B32Arg"},
+ {
"experimental_method":["X-ray diffraction"],
- "pdb_id":"1mso",
- "resolution":1.0,
- "title":"T6 Human Insulin at 1.0 A Resolution"},
+ "pdb_id":"4cxn",
+ "resolution":1.7,
+ "title":"Crystal structure of human insulin analogue (NMe-AlaB8)-insulin crystal form I"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"4cxn",
+ "resolution":1.7,
+ "title":"Crystal structure of human insulin analogue (NMe-AlaB8)-insulin crystal form I"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"2r34",
+ "resolution":2.25,
+ "title":"Crystal structure of MN human arg-insulin"},
+ {
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"2kxk",
+ "title":"Human Insulin Mutant A22Gly-B31Lys-B32Arg"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"2wrx",
+ "resolution":1.5,
+ "title":"Semi-synthetic analogue of human insulin NMeAlaB26-insulin at pH 3.0"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"2wrx",
+ "resolution":1.5,
+ "title":"Semi-synthetic analogue of human insulin NMeAlaB26-insulin at pH 3.0"},
{
"experimental_method":["Solution NMR"],
"pdb_id":"1mhi",
"pdb_id":"1aiy",
"title":"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 10 STRUCTURES"},
{
- "experimental_method":["Solution NMR"],
- "pdb_id":"2k91",
- "title":"Enhancing the activity of insulin by stereospecific unfolding"},
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"1mso",
+ "resolution":1.0,
+ "title":"T6 Human Insulin at 1.0 A Resolution"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"2g56",
+ "resolution":2.2,
+ "title":"crystal structure of human insulin-degrading enzyme in complex with insulin B chain"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2k91",
- "title":"Enhancing the activity of insulin by stereospecific unfolding"},
+ "pdb_id":"2aiy",
+ "title":"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES"},
{
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"4iyf",
- "resolution":1.8,
- "title":"Insulin glargine crystal structure 2"},
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"2kqq",
+ "title":"NMR structure of human insulin mutant gly-b8-d-ala, his-b10-asp, pro-b28-lys, lys-b29-pro, 20 structures"},
{
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"4iyf",
- "resolution":1.8,
- "title":"Insulin glargine crystal structure 2"},
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"2l1y",
+ "title":"NMR Structure of human insulin mutant GLY-B20-D-ALA, GLY-B23-D-ALA PRO-B28-LYS, LYS-B29-PRO, 20 Structures"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"5aiy",
- "title":"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 'RED' SUBSTATE, AVERAGE STRUCTURE"},
+ "pdb_id":"2n2v",
+ "title":"Solution structure of [B26-B29 triazole cross-linked]-insulin analogue at pH 1.9"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"5aiy",
- "title":"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 'RED' SUBSTATE, AVERAGE STRUCTURE"},
+ "pdb_id":"2n2w",
+ "title":"Solution structure of [B26-B29 triazole cross-linked]-insulin analogue at pH 8.0"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"4une",
"title":"Human insulin B26Phe mutant crystal structure"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"5hqi",
- "resolution":0.97,
- "title":"Insulin with proline analog HzP at position B28 in the T2 state"},
+ "pdb_id":"4ung",
+ "resolution":1.81,
+ "title":"Human insulin B26Asn mutant crystal structure"},
{
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"5hqi",
- "resolution":0.97,
- "title":"Insulin with proline analog HzP at position B28 in the T2 state"},
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"2mpi",
+ "title":"Solution structure of B24G insulin"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2mli",
- "title":"NMR structure of B25-(alpha, beta)-dehydro-phenylalanine insulin"},
+ "pdb_id":"2mpi",
+ "title":"Solution structure of B24G insulin"},
{
"experimental_method":["Solution NMR"],
"pdb_id":"2mpg",
"title":"Solution structure of the [AibB8,LysB28,ProB29]-insulin analogue"},
{
"experimental_method":["Solution NMR"],
+ "pdb_id":"2mli",
+ "title":"NMR structure of B25-(alpha, beta)-dehydro-phenylalanine insulin"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"3w80",
+ "resolution":1.4,
+ "title":"Crystal structure of dodecamer human insulin with double C-axis length of the hexamer 2 Zn insulin cell"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"3w80",
+ "resolution":1.4,
+ "title":"Crystal structure of dodecamer human insulin with double C-axis length of the hexamer 2 Zn insulin cell"},
+ {
+ "experimental_method":["Solution NMR"],
"pdb_id":"4aiy",
"title":"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 'GREEN' SUBSTATE, AVERAGE STRUCTURE"},
{
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4eww",
- "resolution":2.3,
- "title":"Human Insulin"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"3w80",
- "resolution":1.4,
- "title":"Crystal structure of dodecamer human insulin with double C-axis length of the hexamer 2 Zn insulin cell"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"3w80",
- "resolution":1.4,
- "title":"Crystal structure of dodecamer human insulin with double C-axis length of the hexamer 2 Zn insulin cell"},
- {
- "experimental_method":["X-ray diffraction"],
"pdb_id":"3tt8",
"resolution":1.12,
"title":"Crystal Structure Analysis of Cu Human Insulin Derivative"},
"resolution":1.12,
"title":"Crystal Structure Analysis of Cu Human Insulin Derivative"},
{
- "experimental_method":["Solution NMR"],
- "pdb_id":"2n2v",
- "title":"Solution structure of [B26-B29 triazole cross-linked]-insulin analogue at pH 1.9"},
- {
- "experimental_method":["Solution NMR"],
- "pdb_id":"2n2w",
- "title":"Solution structure of [B26-B29 triazole cross-linked]-insulin analogue at pH 8.0"},
- {
- "experimental_method":["Solution NMR"],
- "pdb_id":"2n2x",
- "title":"Solution structure of [GlyB24,B27-B29 triazole cross-linked]-insulin analogue at pH 1.9"},
- {
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4ung",
- "resolution":1.81,
- "title":"Human insulin B26Asn mutant crystal structure"},
+ "pdb_id":"4iyf",
+ "resolution":1.8,
+ "title":"Insulin glargine crystal structure 2"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2r34",
- "resolution":2.25,
- "title":"Crystal structure of MN human arg-insulin"},
+ "pdb_id":"4iyf",
+ "resolution":1.8,
+ "title":"Insulin glargine crystal structure 2"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2mpi",
- "title":"Solution structure of B24G insulin"},
+ "pdb_id":"5aiy",
+ "title":"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 'RED' SUBSTATE, AVERAGE STRUCTURE"},
{
"experimental_method":["Solution NMR"],
- "pdb_id":"2mpi",
- "title":"Solution structure of B24G insulin"},
+ "pdb_id":"5aiy",
+ "title":"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 'RED' SUBSTATE, AVERAGE STRUCTURE"},
{
"experimental_method":["Solution NMR"],
"pdb_id":"5mhd",
"pdb_id":"5mhd",
"title":"Biosynthetic engineered A22S-B3K-B31R human insulin monomer structure in water/acetonitrile solutions."},
{
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"2n2x",
+ "title":"Solution structure of [GlyB24,B27-B29 triazole cross-linked]-insulin analogue at pH 1.9"},
+ {
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2ws1",
- "resolution":1.6,
- "title":"Semi-synthetic analogue of human insulin NMeTyrB26-insulin in monomer form"},
+ "pdb_id":"5hqi",
+ "resolution":0.97,
+ "title":"Insulin with proline analog HzP at position B28 in the T2 state"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2ws1",
- "resolution":1.6,
- "title":"Semi-synthetic analogue of human insulin NMeTyrB26-insulin in monomer form"},
+ "pdb_id":"5hqi",
+ "resolution":0.97,
+ "title":"Insulin with proline analog HzP at position B28 in the T2 state"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4f1c",
- "resolution":1.7,
+ "pdb_id":"4eww",
+ "resolution":2.3,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4f1d",
- "resolution":1.637,
- "title":"Human Insulin"},
+ "pdb_id":"2wru",
+ "resolution":1.57,
+ "title":"Semi-synthetic highly active analogue of human insulin NMeAlaB26-DTI- NH2"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4f0o",
- "resolution":1.672,
- "title":"Human Insulin"},
+ "pdb_id":"2wru",
+ "resolution":1.57,
+ "title":"Semi-synthetic highly active analogue of human insulin NMeAlaB26-DTI- NH2"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4f1g",
- "resolution":1.637,
- "title":"Human insulin"},
+ "pdb_id":"4f1a",
+ "resolution":1.8,
+ "title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4f4v",
- "resolution":1.637,
+ "pdb_id":"4f1a",
+ "resolution":1.8,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4f8f",
- "resolution":1.676,
+ "pdb_id":"4f4t",
+ "resolution":1.637,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4f1f",
- "resolution":1.684,
+ "pdb_id":"4f0o",
+ "resolution":1.672,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2wru",
- "resolution":1.57,
- "title":"Semi-synthetic highly active analogue of human insulin NMeAlaB26-DTI- NH2"},
+ "pdb_id":"2ws1",
+ "resolution":1.6,
+ "title":"Semi-synthetic analogue of human insulin NMeTyrB26-insulin in monomer form"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2wru",
- "resolution":1.57,
- "title":"Semi-synthetic highly active analogue of human insulin NMeAlaB26-DTI- NH2"},
+ "pdb_id":"2ws1",
+ "resolution":1.6,
+ "title":"Semi-synthetic analogue of human insulin NMeTyrB26-insulin in monomer form"},
{
- "experimental_method":["Solution NMR"],
- "pdb_id":"2kqq",
- "title":"NMR structure of human insulin mutant gly-b8-d-ala, his-b10-asp, pro-b28-lys, lys-b29-pro, 20 structures"},
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"4fka",
+ "resolution":1.08,
+ "title":"High resolution structure of the manganese derivative of insulin"},
{
- "experimental_method":["Solution NMR"],
- "pdb_id":"2l1y",
- "title":"NMR Structure of human insulin mutant GLY-B20-D-ALA, GLY-B23-D-ALA PRO-B28-LYS, LYS-B29-PRO, 20 Structures"},
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"4f1g",
+ "resolution":1.637,
+ "title":"Human insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4f1a",
- "resolution":1.8,
+ "pdb_id":"4f8f",
+ "resolution":1.676,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4f1a",
- "resolution":1.8,
+ "pdb_id":"4f1d",
+ "resolution":1.637,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4f4t",
- "resolution":1.637,
+ "pdb_id":"4f1b",
+ "resolution":1.591,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4f1b",
- "resolution":1.591,
+ "pdb_id":"4f1c",
+ "resolution":1.7,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"1jca",
- "resolution":2.5,
- "title":"Non-standard Design of Unstable Insulin Analogues with Enhanced Activity"},
+ "pdb_id":"4f1f",
+ "resolution":1.684,
+ "title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"3bxq",
- "resolution":1.3,
- "title":"The structure of a mutant insulin uncouples receptor binding from protein allostery. An electrostatic block to the TR transition"},
+ "pdb_id":"4f4v",
+ "resolution":1.637,
+ "title":"Human Insulin"},
+ {
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"1aiy",
+ "title":"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 10 STRUCTURES"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"1htv",
"pdb_id":"1ai0",
"title":"R6 HUMAN INSULIN HEXAMER (NON-SYMMETRIC), NMR, 10 STRUCTURES"},
{
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"3bxq",
+ "resolution":1.3,
+ "title":"The structure of a mutant insulin uncouples receptor binding from protein allostery. An electrostatic block to the TR transition"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"1jca",
+ "resolution":2.5,
+ "title":"Non-standard Design of Unstable Insulin Analogues with Enhanced Activity"},
+ {
"experimental_method":["Solution NMR"],
- "pdb_id":"1aiy",
- "title":"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 10 STRUCTURES"},
+ "pdb_id":"2kqq",
+ "title":"NMR structure of human insulin mutant gly-b8-d-ala, his-b10-asp, pro-b28-lys, lys-b29-pro, 20 structures"},
+ {
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"2l1y",
+ "title":"NMR Structure of human insulin mutant GLY-B20-D-ALA, GLY-B23-D-ALA PRO-B28-LYS, LYS-B29-PRO, 20 Structures"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"6ver",
+ "resolution":1.047,
+ "title":"Human insulin analog: [GluB10,TyrB20]-DOI"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"6ver",
+ "resolution":1.047,
+ "title":"Human insulin analog: [GluB10,TyrB20]-DOI"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"5bts",
"title":"Structural and biophysical characterization of a covalent insulin dimer formed during storage of neutral formulation of human insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"5usp",
- "resolution":1.174,
- "title":"Insulin with proline analog Pip at position B28 in the T2 state"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"5usp",
- "resolution":1.174,
- "title":"Insulin with proline analog Pip at position B28 in the T2 state"},
- {
- "experimental_method":["X-ray diffraction"],
"pdb_id":"5bpo",
"resolution":1.9,
"title":"Human insulin with intra-chain chemical crosslink between modified B27 and B29"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"5uu2",
- "resolution":1.223,
- "title":"Insulin with proline analog ThioP at position B28 in the T2 state"},
- {
- "experimental_method":["X-ray diffraction"],
"pdb_id":"5urt",
"resolution":1.18,
"title":"Insulin with proline analog DhP at position B28 in the T2 state"},
{
"experimental_method":["X-ray diffraction"],
+ "pdb_id":"5usp",
+ "resolution":1.174,
+ "title":"Insulin with proline analog Pip at position B28 in the T2 state"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"5usp",
+ "resolution":1.174,
+ "title":"Insulin with proline analog Pip at position B28 in the T2 state"},
+ {
+ "experimental_method":["X-ray diffraction"],
"pdb_id":"6h3m",
"resolution":1.821,
"title":"The crystal structure of a human seleno-insulin analog"},
"title":"The crystal structure of a human seleno-insulin analog"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"6ver",
- "resolution":1.047,
- "title":"Human insulin analog: [GluB10,TyrB20]-DOI"},
+ "pdb_id":"4rxw",
+ "resolution":1.73,
+ "title":"Crystal Structure of the cobalt human insulin derivative"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"6ver",
- "resolution":1.047,
- "title":"Human insulin analog: [GluB10,TyrB20]-DOI"},
+ "pdb_id":"4rxw",
+ "resolution":1.73,
+ "title":"Crystal Structure of the cobalt human insulin derivative"},
+ {
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"2n2v",
+ "title":"Solution structure of [B26-B29 triazole cross-linked]-insulin analogue at pH 1.9"},
+ {
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"2n2w",
+ "title":"Solution structure of [B26-B29 triazole cross-linked]-insulin analogue at pH 8.0"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4ewx",
- "resolution":2.201,
+ "pdb_id":"4eyd",
+ "resolution":1.471,
+ "title":"Human Insulin"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"4eyd",
+ "resolution":1.471,
+ "title":"Human Insulin"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"4eyn",
+ "resolution":1.532,
+ "title":"Human Insulin"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"4eyn",
+ "resolution":1.532,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4eww",
- "resolution":2.3,
+ "pdb_id":"4ewx",
+ "resolution":2.201,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4exx",
- "resolution":1.55,
+ "pdb_id":"4eyp",
+ "resolution":1.591,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4eyp",
- "resolution":1.591,
+ "pdb_id":"4exx",
+ "resolution":1.55,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4ewz",
- "resolution":1.791,
- "title":"Human Insulin"},
+ "pdb_id":"5usv",
+ "resolution":1.3,
+ "title":"Insulin with proline analog AzeP at position B28 in the T2 state"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4ewz",
- "resolution":1.791,
- "title":"Human Insulin"},
+ "pdb_id":"5usv",
+ "resolution":1.3,
+ "title":"Insulin with proline analog AzeP at position B28 in the T2 state"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4ex0",
- "resolution":1.86,
- "title":"Human Insulin"},
+ "pdb_id":"5uu2",
+ "resolution":1.223,
+ "title":"Insulin with proline analog ThioP at position B28 in the T2 state"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4ex0",
- "resolution":1.86,
+ "pdb_id":"4ex1",
+ "resolution":1.657,
"title":"Human Insulin"},
{
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"4eyd",
- "resolution":1.471,
- "title":"Human Insulin"},
+ "experimental_method":["Solution NMR"],
+ "pdb_id":"2n2x",
+ "title":"Solution structure of [GlyB24,B27-B29 triazole cross-linked]-insulin analogue at pH 1.9"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4eyd",
+ "pdb_id":"4ey9",
"resolution":1.471,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4ex1",
- "resolution":1.657,
+ "pdb_id":"4ey9",
+ "resolution":1.471,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
"resolution":2.05,
"title":"Human insulin in complex with cucurbit[7]uril"},
{
- "experimental_method":["Solution NMR"],
- "pdb_id":"2n2v",
- "title":"Solution structure of [B26-B29 triazole cross-linked]-insulin analogue at pH 1.9"},
- {
- "experimental_method":["Solution NMR"],
- "pdb_id":"2n2w",
- "title":"Solution structure of [B26-B29 triazole cross-linked]-insulin analogue at pH 8.0"},
- {
- "experimental_method":["Solution NMR"],
- "pdb_id":"2n2x",
- "title":"Solution structure of [GlyB24,B27-B29 triazole cross-linked]-insulin analogue at pH 1.9"},
- {
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4ey9",
- "resolution":1.471,
+ "pdb_id":"4ex0",
+ "resolution":1.86,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4ey9",
- "resolution":1.471,
+ "pdb_id":"4ex0",
+ "resolution":1.86,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4fka",
- "resolution":1.08,
- "title":"High resolution structure of the manganese derivative of insulin"},
+ "pdb_id":"4eww",
+ "resolution":2.3,
+ "title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4eyn",
- "resolution":1.532,
+ "pdb_id":"4ewz",
+ "resolution":1.791,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4eyn",
- "resolution":1.532,
+ "pdb_id":"4ewz",
+ "resolution":1.791,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4rxw",
- "resolution":1.73,
- "title":"Crystal Structure of the cobalt human insulin derivative"},
+ "pdb_id":"5c0d",
+ "resolution":1.68,
+ "title":"HLA-A02 carrying AQWGPDPAAA"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4rxw",
- "resolution":1.73,
- "title":"Crystal Structure of the cobalt human insulin derivative"},
+ "pdb_id":"3ir0",
+ "resolution":2.2,
+ "title":"Crystal Structure of Human Insulin complexed with Cu+2 metal ion"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"5usv",
- "resolution":1.3,
- "title":"Insulin with proline analog AzeP at position B28 in the T2 state"},
+ "pdb_id":"3ir0",
+ "resolution":2.2,
+ "title":"Crystal Structure of Human Insulin complexed with Cu+2 metal ion"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"5usv",
- "resolution":1.3,
- "title":"Insulin with proline analog AzeP at position B28 in the T2 state"},
+ "pdb_id":"3exx",
+ "resolution":1.35,
+ "title":"Structure of the T6 human insulin derivative with nickel at 1.35 A resolution"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"3exx",
+ "resolution":1.35,
+ "title":"Structure of the T6 human insulin derivative with nickel at 1.35 A resolution"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"2wrv",
"title":"Crystal structure form ultalente insulin microcrystals"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"3exx",
- "resolution":1.35,
- "title":"Structure of the T6 human insulin derivative with nickel at 1.35 A resolution"},
+ "pdb_id":"1b9e",
+ "resolution":2.5,
+ "title":"HUMAN INSULIN MUTANT SERB9GLU"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"3exx",
- "resolution":1.35,
- "title":"Structure of the T6 human insulin derivative with nickel at 1.35 A resolution"},
+ "pdb_id":"1b9e",
+ "resolution":2.5,
+ "title":"HUMAN INSULIN MUTANT SERB9GLU"},
{
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"2vjz",
- "resolution":1.8,
- "title":"Crystal structure form ultalente insulin microcrystals"},
+ "experimental_method":["X-ray powder diffraction"],
+ "pdb_id":"1fub",
+ "title":"FIRST PROTEIN STRUCTURE DETERMINED FROM X-RAY POWDER DIFFRACTION DATA"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4f1c",
- "resolution":1.7,
+ "pdb_id":"4f51",
+ "resolution":1.637,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4f1d",
+ "pdb_id":"4f4t",
"resolution":1.637,
"title":"Human Insulin"},
{
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4gbc",
- "resolution":1.778,
- "title":"Crystal structure of aspart insulin at pH 6.5"},
+ "pdb_id":"2vjz",
+ "resolution":1.8,
+ "title":"Crystal structure form ultalente insulin microcrystals"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4gbn",
- "resolution":1.872,
- "title":"Crystal structure of aspart insulin at pH 6.5"},
+ "pdb_id":"4fka",
+ "resolution":1.08,
+ "title":"High resolution structure of the manganese derivative of insulin"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"4f1g",
"title":"Human insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4f4v",
- "resolution":1.637,
- "title":"Human Insulin"},
+ "pdb_id":"2r36",
+ "resolution":2.0,
+ "title":"Crystal structure of ni human ARG-insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4f51",
- "resolution":1.637,
- "title":"Human Insulin"},
+ "pdb_id":"4gbi",
+ "resolution":2.502,
+ "title":"Crystal structure of aspart insulin at pH 6.5"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4f1f",
- "resolution":1.684,
+ "pdb_id":"4f8f",
+ "resolution":1.676,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4f8f",
- "resolution":1.676,
+ "pdb_id":"4f1d",
+ "resolution":1.637,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4gbi",
- "resolution":2.502,
+ "pdb_id":"4gbc",
+ "resolution":1.778,
+ "title":"Crystal structure of aspart insulin at pH 6.5"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"4gbn",
+ "resolution":1.872,
"title":"Crystal structure of aspart insulin at pH 6.5"},
{
"experimental_method":["X-ray diffraction"],
"title":"Human insulin analogue (D-ProB8)-insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2r36",
- "resolution":2.0,
- "title":"Crystal structure of ni human ARG-insulin"},
+ "pdb_id":"4f1b",
+ "resolution":1.591,
+ "title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4f4t",
- "resolution":1.637,
+ "pdb_id":"4f1c",
+ "resolution":1.7,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4f1b",
- "resolution":1.591,
+ "pdb_id":"4f1f",
+ "resolution":1.684,
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"3ir0",
- "resolution":2.2,
- "title":"Crystal Structure of Human Insulin complexed with Cu+2 metal ion"},
+ "pdb_id":"4f4v",
+ "resolution":1.637,
+ "title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"3ir0",
- "resolution":2.2,
- "title":"Crystal Structure of Human Insulin complexed with Cu+2 metal ion"},
+ "pdb_id":"2ceu",
+ "resolution":1.8,
+ "title":"Despentapeptide insulin in acetic acid (pH 2)"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"1jca",
- "resolution":2.5,
- "title":"Non-standard Design of Unstable Insulin Analogues with Enhanced Activity"},
+ "pdb_id":"2ceu",
+ "resolution":1.8,
+ "title":"Despentapeptide insulin in acetic acid (pH 2)"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"3bxq",
"title":"The structure of a mutant insulin uncouples receptor binding from protein allostery. An electrostatic block to the TR transition"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"1b9e",
- "resolution":2.5,
- "title":"HUMAN INSULIN MUTANT SERB9GLU"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"1b9e",
+ "pdb_id":"1jca",
"resolution":2.5,
- "title":"HUMAN INSULIN MUTANT SERB9GLU"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"2ceu",
- "resolution":1.8,
- "title":"Despentapeptide insulin in acetic acid (pH 2)"},
+ "title":"Non-standard Design of Unstable Insulin Analogues with Enhanced Activity"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2ceu",
- "resolution":1.8,
- "title":"Despentapeptide insulin in acetic acid (pH 2)"},
- {
- "experimental_method":["X-ray powder diffraction"],
- "pdb_id":"1fub",
- "title":"FIRST PROTEIN STRUCTURE DETERMINED FROM X-RAY POWDER DIFFRACTION DATA"},
+ "pdb_id":"5cny",
+ "resolution":1.7,
+ "title":"Crystal Structure of human zinc insulin at pH 5.5"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"5bpo",
"title":"Human insulin with intra-chain chemical crosslink between modified B27 and B29"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"5uu2",
- "resolution":1.223,
- "title":"Insulin with proline analog ThioP at position B28 in the T2 state"},
+ "pdb_id":"5urt",
+ "resolution":1.18,
+ "title":"Insulin with proline analog DhP at position B28 in the T2 state"},
{
"experimental_method":["Solution NMR"],
"pdb_id":"2mli",
"title":"NMR structure of B25-(alpha, beta)-dehydro-phenylalanine insulin"},
{
"experimental_method":["X-ray diffraction"],
+ "pdb_id":"4iuz",
+ "resolution":1.6,
+ "title":"High resolution crystal structure of racemic ester insulin"},
+ {
+ "experimental_method":["X-ray diffraction"],
"pdb_id":"4ey1",
"resolution":1.471,
"title":"Human Insulin"},
"title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4ex1",
- "resolution":1.657,
- "title":"Human Insulin"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"4iuz",
- "resolution":1.6,
- "title":"High resolution crystal structure of racemic ester insulin"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"5urt",
- "resolution":1.18,
- "title":"Insulin with proline analog DhP at position B28 in the T2 state"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"4fka",
- "resolution":1.08,
- "title":"High resolution structure of the manganese derivative of insulin"},
+ "pdb_id":"5uu2",
+ "resolution":1.223,
+ "title":"Insulin with proline analog ThioP at position B28 in the T2 state"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"5cny",
- "resolution":1.7,
- "title":"Crystal Structure of human zinc insulin at pH 5.5"},
+ "pdb_id":"4ex1",
+ "resolution":1.657,
+ "title":"Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2vk0",
- "resolution":2.2,
- "title":"Crystal structure form ultalente insulin microcrystals"},
+ "pdb_id":"2omi",
+ "resolution":2.24,
+ "title":"Structure of human insulin cocrystallized with protamine"},
{
"experimental_method":["Solution NMR"],
"pdb_id":"2k9r",
"title":"Enhancing the activity of insulin by stereospecific unfolding"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2omi",
- "resolution":2.24,
- "title":"Structure of human insulin cocrystallized with protamine"},
+ "pdb_id":"2g54",
+ "resolution":2.25,
+ "title":"Crystal structure of Zn-bound human insulin-degrading enzyme in complex with insulin B chain"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"2vk0",
+ "resolution":2.2,
+ "title":"Crystal structure form ultalente insulin microcrystals"},
+ {
+ "experimental_method":["X-ray powder diffraction"],
+ "pdb_id":"1fub",
+ "title":"FIRST PROTEIN STRUCTURE DETERMINED FROM X-RAY POWDER DIFFRACTION DATA"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"2vjz",
"title":"Crystal structure form ultalente insulin microcrystals"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4gbn",
- "resolution":1.872,
- "title":"Crystal structure of aspart insulin at pH 6.5"},
+ "pdb_id":"2r36",
+ "resolution":2.0,
+ "title":"Crystal structure of ni human ARG-insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4gbl",
- "resolution":2.5,
+ "pdb_id":"4gbk",
+ "resolution":2.4,
"title":"Crystal structure of aspart insulin at pH 8.5"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4gbl",
- "resolution":2.5,
+ "pdb_id":"4gbk",
+ "resolution":2.4,
"title":"Crystal structure of aspart insulin at pH 8.5"},
{
"experimental_method":["X-ray diffraction"],
"title":"Crystal structure of aspart insulin at pH 6.5"},
{
"experimental_method":["X-ray diffraction"],
+ "pdb_id":"4gbc",
+ "resolution":1.778,
+ "title":"Crystal structure of aspart insulin at pH 6.5"},
+ {
+ "experimental_method":["X-ray diffraction"],
"pdb_id":"4cy7",
"resolution":1.4,
"title":"Crystal structure of human insulin analogue (NMe-AlaB8)-insulin crystal form II"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2r36",
- "resolution":2.0,
- "title":"Crystal structure of ni human ARG-insulin"},
+ "pdb_id":"4gbn",
+ "resolution":1.872,
+ "title":"Crystal structure of aspart insulin at pH 6.5"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4gbc",
- "resolution":1.778,
- "title":"Crystal structure of aspart insulin at pH 6.5"},
+ "pdb_id":"4gbl",
+ "resolution":2.5,
+ "title":"Crystal structure of aspart insulin at pH 8.5"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"4gbl",
+ "resolution":2.5,
+ "title":"Crystal structure of aspart insulin at pH 8.5"},
{
"experimental_method":["X-ray powder diffraction"],
"pdb_id":"1fu2",
"resolution":2.0,
"title":"Crystal structure of an unstable insulin analog with native activity."},
{
- "experimental_method":["X-ray powder diffraction"],
- "pdb_id":"1fub",
- "title":"FIRST PROTEIN STRUCTURE DETERMINED FROM X-RAY POWDER DIFFRACTION DATA"},
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"6s4i",
+ "resolution":1.511,
+ "title":"Crystal structure of zinc free A14E, B25H, B29K(N(eps)-[2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)amino]ethoxy)ethoxy]acetylamino)ethoxy]ethoxy)acetyl]), desB30 human insulin"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"6s4i",
+ "resolution":1.511,
+ "title":"Crystal structure of zinc free A14E, B25H, B29K(N(eps)-[2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)amino]ethoxy)ethoxy]acetylamino)ethoxy]ethoxy)acetyl]), desB30 human insulin"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"6p4z",
+ "resolution":1.8,
+ "title":"Structure of gadolinium-caged cobalt (III) insulin hexamer"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"5co9",
+ "resolution":1.92,
+ "title":"Crystal structure of human zinc insulin at pH 6.5"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"5cny",
+ "resolution":1.7,
+ "title":"Crystal Structure of human zinc insulin at pH 5.5"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"5co2",
"title":"Human insulin with intra-chain chemical crosslink between modified B24 and B29"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"6s4i",
- "resolution":1.511,
- "title":"Crystal structure of zinc free A14E, B25H, B29K(N(eps)-[2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)amino]ethoxy)ethoxy]acetylamino)ethoxy]ethoxy)acetyl]), desB30 human insulin"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"6s4i",
- "resolution":1.511,
- "title":"Crystal structure of zinc free A14E, B25H, B29K(N(eps)-[2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)amino]ethoxy)ethoxy]acetylamino)ethoxy]ethoxy)acetyl]), desB30 human insulin"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"6p4z",
- "resolution":1.8,
- "title":"Structure of gadolinium-caged cobalt (III) insulin hexamer"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"6gv0",
- "resolution":1.26,
- "title":"Insulin glulisine"},
- {
- "experimental_method":["X-ray diffraction"],
"pdb_id":"6vet",
"resolution":1.46,
"title":"Human insulin analog: [GluB10,HisA8,ArgA9,TyrB20]-DOI"},
"title":"Human insulin analog: [GluB10,HisA8,ArgA9,TyrB20]-DOI"},
{
"experimental_method":["X-ray diffraction"],
+ "pdb_id":"6gv0",
+ "resolution":1.26,
+ "title":"Insulin glulisine"},
+ {
+ "experimental_method":["X-ray diffraction"],
"pdb_id":"4iuz",
"resolution":1.6,
"title":"High resolution crystal structure of racemic ester insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4gbk",
- "resolution":2.4,
- "title":"Crystal structure of aspart insulin at pH 8.5"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"4gbk",
- "resolution":2.4,
- "title":"Crystal structure of aspart insulin at pH 8.5"},
- {
- "experimental_method":["X-ray diffraction"],
"pdb_id":"4efx",
"resolution":1.98,
"title":"Highly biologically active insulin with additional disulfide bond"},
"resolution":1.98,
"title":"Highly biologically active insulin with additional disulfide bond"},
{
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"5co9",
- "resolution":1.92,
- "title":"Crystal structure of human zinc insulin at pH 6.5"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"5cny",
- "resolution":1.7,
- "title":"Crystal Structure of human zinc insulin at pH 5.5"},
+ "experimental_method":["Electron Microscopy"],
+ "pdb_id":"6ce7",
+ "resolution":7.4,
+ "title":"Insulin Receptor ectodomain in complex with one insulin molecule"},
{
"experimental_method":["Solution NMR"],
"pdb_id":"2jmn",
"title":"NMR structure of human insulin mutant His-B10-Asp, Pro-B28-Lys, Lys-B29-Pro, 20 structures"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"3e7z",
- "resolution":1.7,
- "title":"Structure of human insulin"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"3e7z",
- "resolution":1.7,
- "title":"Structure of human insulin"},
+ "pdb_id":"3utq",
+ "resolution":1.67,
+ "title":"Human HLA-A*0201-ALWGPDPAAA"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2w44",
- "resolution":2.0,
- "title":"Structure DeltaA1-A4 insulin"},
+ "pdb_id":"2omi",
+ "resolution":2.24,
+ "title":"Structure of human insulin cocrystallized with protamine"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"3e7y",
"title":"Structure of human insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2omi",
- "resolution":2.24,
- "title":"Structure of human insulin cocrystallized with protamine"},
+ "pdb_id":"1ev6",
+ "resolution":1.9,
+ "title":"Structure of the monoclinic form of the M-cresol/insulin R6 hexamer"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"1trz",
+ "resolution":1.6,
+ "title":"CRYSTALLOGRAPHIC EVIDENCE FOR DUAL COORDINATION AROUND ZINC IN THE T3R3 HUMAN INSULIN HEXAMER"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"1trz",
+ "resolution":1.6,
+ "title":"CRYSTALLOGRAPHIC EVIDENCE FOR DUAL COORDINATION AROUND ZINC IN THE T3R3 HUMAN INSULIN HEXAMER"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"2ws7",
"title":"Semi-synthetic analogue of human insulin ProB26-DTI"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4cy7",
+ "pdb_id":"4nib",
"resolution":1.4,
- "title":"Crystal structure of human insulin analogue (NMe-AlaB8)-insulin crystal form II"},
+ "title":"Crystal structure of human insulin mutant B20 D-ala, B23 D-ala"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"4nib",
"title":"Crystal structure of human insulin mutant B20 D-ala, B23 D-ala"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4nib",
+ "pdb_id":"4cy7",
"resolution":1.4,
- "title":"Crystal structure of human insulin mutant B20 D-ala, B23 D-ala"},
+ "title":"Crystal structure of human insulin analogue (NMe-AlaB8)-insulin crystal form II"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"1qj0",
"resolution":2.4,
"title":"HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR"},
{
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"1uz9",
- "resolution":1.6,
- "title":"Crystallographic and solution studies of N-lithocholyl insulin: a new generation of prolonged-acting insulins."},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"1uz9",
- "resolution":1.6,
- "title":"Crystallographic and solution studies of N-lithocholyl insulin: a new generation of prolonged-acting insulins."},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"1trz",
- "resolution":1.6,
- "title":"CRYSTALLOGRAPHIC EVIDENCE FOR DUAL COORDINATION AROUND ZINC IN THE T3R3 HUMAN INSULIN HEXAMER"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"1trz",
- "resolution":1.6,
- "title":"CRYSTALLOGRAPHIC EVIDENCE FOR DUAL COORDINATION AROUND ZINC IN THE T3R3 HUMAN INSULIN HEXAMER"},
- {
"experimental_method":["X-ray powder diffraction"],
"pdb_id":"1fu2",
"title":"FIRST PROTEIN STRUCTURE DETERMINED FROM X-RAY POWDER DIFFRACTION DATA"},
"title":"The structure of the resorcinol/insulin R6 hexamer"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"1ev3",
- "resolution":1.78,
- "title":"Structure of the rhombohedral form of the M-cresol/insulin R6 hexamer"},
+ "pdb_id":"1ev6",
+ "resolution":1.9,
+ "title":"Structure of the monoclinic form of the M-cresol/insulin R6 hexamer"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"1guj",
"title":"Insulin at pH 2: structural analysis of the conditions promoting insulin fibre formation."},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"1ev6",
- "resolution":1.9,
- "title":"Structure of the monoclinic form of the M-cresol/insulin R6 hexamer"},
+ "pdb_id":"1ev3",
+ "resolution":1.78,
+ "title":"Structure of the rhombohedral form of the M-cresol/insulin R6 hexamer"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"1ev6",
- "resolution":1.9,
- "title":"Structure of the monoclinic form of the M-cresol/insulin R6 hexamer"},
+ "pdb_id":"2w44",
+ "resolution":2.0,
+ "title":"Structure DeltaA1-A4 insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"6s4j",
- "resolution":1.5,
- "title":"Crystal structure of zinc free A14E, B25H, B29K(N(eps)-[2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)amino]ethoxy)ethoxy]acetylamino)ethoxy]ethoxy)acetyl]), desB27, desB30 human insulin"},
+ "pdb_id":"1uz9",
+ "resolution":1.6,
+ "title":"Crystallographic and solution studies of N-lithocholyl insulin: a new generation of prolonged-acting insulins."},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"6s4j",
- "resolution":1.5,
- "title":"Crystal structure of zinc free A14E, B25H, B29K(N(eps)-[2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)amino]ethoxy)ethoxy]acetylamino)ethoxy]ethoxy)acetyl]), desB27, desB30 human insulin"},
+ "pdb_id":"1uz9",
+ "resolution":1.6,
+ "title":"Crystallographic and solution studies of N-lithocholyl insulin: a new generation of prolonged-acting insulins."},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"3e7z",
+ "resolution":1.7,
+ "title":"Structure of human insulin"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"3e7z",
+ "resolution":1.7,
+ "title":"Structure of human insulin"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"6gnq",
+ "resolution":2.2,
+ "title":"Monoclinic crystalline form of human insulin, complexed with meta-cresol"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"7s4y",
+ "resolution":1.71,
+ "title":"Serial Macromolecular Crystallography at ALBA Synchrotron Light Source - Insulin"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"7s4y",
+ "resolution":1.71,
+ "title":"Serial Macromolecular Crystallography at ALBA Synchrotron Light Source - Insulin"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"5co6",
"title":"Structure of gadolinium-caged cobalt (III) insulin hexamer"},
{
"experimental_method":["X-ray diffraction"],
+ "pdb_id":"5co9",
+ "resolution":1.92,
+ "title":"Crystal structure of human zinc insulin at pH 6.5"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"6s4j",
+ "resolution":1.5,
+ "title":"Crystal structure of zinc free A14E, B25H, B29K(N(eps)-[2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)amino]ethoxy)ethoxy]acetylamino)ethoxy]ethoxy)acetyl]), desB27, desB30 human insulin"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"6s4j",
+ "resolution":1.5,
+ "title":"Crystal structure of zinc free A14E, B25H, B29K(N(eps)-[2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)amino]ethoxy)ethoxy]acetylamino)ethoxy]ethoxy)acetyl]), desB27, desB30 human insulin"},
+ {
+ "experimental_method":["X-ray diffraction"],
"pdb_id":"6gv0",
"resolution":1.26,
"title":"Insulin glulisine"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"6gnq",
- "resolution":2.2,
- "title":"Monoclinic crystalline form of human insulin, complexed with meta-cresol"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"5ems",
- "resolution":2.3,
- "title":"Crystal Structure of an iodinated insulin analog"},
- {
- "experimental_method":["X-ray diffraction"],
"pdb_id":"3zu1",
"resolution":1.6,
"title":"Structure of LysB29(Nepsilon omega-carboxyheptadecanoyl) des(B30) Human Insulin"},
"title":"Structure of LysB29(Nepsilon omega-carboxyheptadecanoyl) des(B30) Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"5co9",
- "resolution":1.92,
- "title":"Crystal structure of human zinc insulin at pH 6.5"},
+ "pdb_id":"5ems",
+ "resolution":2.3,
+ "title":"Crystal Structure of an iodinated insulin analog"},
+ {
+ "experimental_method":["Electron Microscopy"],
+ "pdb_id":"6ce7",
+ "resolution":7.4,
+ "title":"Insulin Receptor ectodomain in complex with one insulin molecule"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"1jk8",
+ "resolution":2.4,
+ "title":"Crystal structure of a human insulin peptide-HLA-DQ8 complex"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"2wby",
"title":"Leucine-zippered human insulin receptor ectodomain with single bound insulin - \"upper\" membrane-distal part"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2olz",
- "resolution":1.7,
- "title":"Structure of human insulin in presence of thiocyanate at pH 7.0"},
+ "pdb_id":"2om1",
+ "resolution":1.97,
+ "title":"Structure of human insulin in presence of thiocyanate at pH 6.5"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2olz",
- "resolution":1.7,
- "title":"Structure of human insulin in presence of thiocyanate at pH 7.0"},
+ "pdb_id":"2om0",
+ "resolution":2.05,
+ "title":"Structure of human insulin in presence of urea at pH 6.5"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"2om0",
+ "resolution":2.05,
+ "title":"Structure of human insulin in presence of urea at pH 6.5"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"3p33",
+ "resolution":2.3,
+ "title":"Insulin fibrillation is the Janus face of induced fit. A chiral clamp stabilizes the native state at the expense of activity"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"2omg",
"title":"Structure of human insulin cocrystallized with protamine and urea"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2w44",
- "resolution":2.0,
- "title":"Structure DeltaA1-A4 insulin"},
+ "pdb_id":"2olz",
+ "resolution":1.7,
+ "title":"Structure of human insulin in presence of thiocyanate at pH 7.0"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2ws7",
- "resolution":2.59,
- "title":"Semi-synthetic analogue of human insulin ProB26-DTI"},
+ "pdb_id":"2olz",
+ "resolution":1.7,
+ "title":"Structure of human insulin in presence of thiocyanate at pH 7.0"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4fg3",
- "resolution":2.001,
- "title":"Crystal Structure Analysis of the Human Insulin"},
+ "pdb_id":"1ben",
+ "resolution":1.4,
+ "title":"INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4fg3",
- "resolution":2.001,
- "title":"Crystal Structure Analysis of the Human Insulin"},
+ "pdb_id":"1g7a",
+ "resolution":1.2,
+ "title":"1.2 A structure of T3R3 human insulin at 100 K"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"1g7a",
+ "resolution":1.2,
+ "title":"1.2 A structure of T3R3 human insulin at 100 K"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"1w8p",
"title":"Structural properties of the B25Tyr-NMe-B26Phe insulin mutant."},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"3p33",
- "resolution":2.3,
- "title":"Insulin fibrillation is the Janus face of induced fit. A chiral clamp stabilizes the native state at the expense of activity"},
+ "pdb_id":"1rwe",
+ "resolution":1.8,
+ "title":"Enhancing the activity of insulin at receptor edge: crystal structure and photo-cross-linking of A8 analogues"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"1rwe",
+ "resolution":1.8,
+ "title":"Enhancing the activity of insulin at receptor edge: crystal structure and photo-cross-linking of A8 analogues"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"1znj",
"title":"Diabetes-Associated Mutations in Human Insulin: Crystal Structure and Photo-Cross-Linking Studies of A-Chain Variant Insulin Wakayama"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"1qj0",
- "resolution":2.4,
- "title":"HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR"},
+ "pdb_id":"4fg3",
+ "resolution":2.001,
+ "title":"Crystal Structure Analysis of the Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"1rwe",
- "resolution":1.8,
- "title":"Enhancing the activity of insulin at receptor edge: crystal structure and photo-cross-linking of A8 analogues"},
+ "pdb_id":"4fg3",
+ "resolution":2.001,
+ "title":"Crystal Structure Analysis of the Human Insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"1rwe",
- "resolution":1.8,
- "title":"Enhancing the activity of insulin at receptor edge: crystal structure and photo-cross-linking of A8 analogues"},
+ "pdb_id":"2ws7",
+ "resolution":2.59,
+ "title":"Semi-synthetic analogue of human insulin ProB26-DTI"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"1evr",
- "resolution":1.9,
- "title":"The structure of the resorcinol/insulin R6 hexamer"},
+ "pdb_id":"1lph",
+ "resolution":2.3,
+ "title":"LYS(B28)PRO(B29)-HUMAN INSULIN"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"1qj0",
+ "resolution":2.4,
+ "title":"HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"1g7b",
"title":"1.3 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"1ben",
- "resolution":1.4,
- "title":"INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"1lph",
- "resolution":2.3,
- "title":"LYS(B28)PRO(B29)-HUMAN INSULIN"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"1lph",
- "resolution":2.3,
- "title":"LYS(B28)PRO(B29)-HUMAN INSULIN"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"2om1",
- "resolution":1.97,
- "title":"Structure of human insulin in presence of thiocyanate at pH 6.5"},
+ "pdb_id":"1evr",
+ "resolution":1.9,
+ "title":"The structure of the resorcinol/insulin R6 hexamer"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2om0",
- "resolution":2.05,
- "title":"Structure of human insulin in presence of urea at pH 6.5"},
+ "pdb_id":"2w44",
+ "resolution":2.0,
+ "title":"Structure DeltaA1-A4 insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2om0",
- "resolution":2.05,
- "title":"Structure of human insulin in presence of urea at pH 6.5"},
+ "pdb_id":"6gnq",
+ "resolution":2.2,
+ "title":"Monoclinic crystalline form of human insulin, complexed with meta-cresol"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"1g7a",
- "resolution":1.2,
- "title":"1.2 A structure of T3R3 human insulin at 100 K"},
+ "pdb_id":"5uru",
+ "resolution":2.41,
+ "title":"Insulin with proline analog DhP at position B28 in the R6 state"},
{
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"1g7a",
- "resolution":1.2,
- "title":"1.2 A structure of T3R3 human insulin at 100 K"},
+ "experimental_method":["Electron Microscopy"],
+ "pdb_id":"7bw7",
+ "resolution":4.1,
+ "title":"Cryo-EM Structure for the Ectodomain of the Full-length Human Insulin Receptor in Complex with 1 Insulin."},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"6ck2",
"title":"Insulin analog containing a YB26W mutation"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"5udp",
- "resolution":1.348,
- "title":"High resolution x-ray crystal structure of synthetic insulin lispro"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"5udp",
- "resolution":1.348,
- "title":"High resolution x-ray crystal structure of synthetic insulin lispro"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"5mt3",
- "resolution":2.02,
- "title":"Human insulin in complex with serotonin and arginine"},
- {
- "experimental_method":["X-ray diffraction"],
"pdb_id":"6nwv",
"resolution":1.601,
"title":"Insulin Lispro Analog"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"6gnq",
- "resolution":2.2,
- "title":"Monoclinic crystalline form of human insulin, complexed with meta-cresol"},
- {
- "experimental_method":["X-ray diffraction"],
"pdb_id":"5hrq",
"resolution":1.28,
"title":"Insulin with proline analog HzP at position B28 in the R6 state"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"5hpr",
- "resolution":1.33,
- "title":"Insulin with proline analog HyP at position B28 in the T2 state"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"5hpr",
- "resolution":1.33,
- "title":"Insulin with proline analog HyP at position B28 in the T2 state"},
+ "pdb_id":"3zqr",
+ "resolution":1.9,
+ "title":"NMePheB25 insulin analogue crystal structure"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"5ems",
- "resolution":2.3,
- "title":"Crystal Structure of an iodinated insulin analog"},
+ "pdb_id":"3zqr",
+ "resolution":1.9,
+ "title":"NMePheB25 insulin analogue crystal structure"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"4ajx",
"title":"Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engineered acylated insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"3v1g",
- "resolution":2.2,
- "title":"Forestalling insulin fibrillation by insertion of a chiral clamp mechanism-based application of protein engineering to global health"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"3v1g",
- "resolution":2.2,
- "title":"Forestalling insulin fibrillation by insertion of a chiral clamp mechanism-based application of protein engineering to global health"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"3zqr",
- "resolution":1.9,
- "title":"NMePheB25 insulin analogue crystal structure"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"3zqr",
- "resolution":1.9,
- "title":"NMePheB25 insulin analogue crystal structure"},
+ "pdb_id":"4akj",
+ "resolution":2.01,
+ "title":"Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engineered acylated insulin"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"4ajz",
"title":"TyrB25,NMePheB26,LysB28,ProB29-insulin analogue crystal structure"},
{
"experimental_method":["X-ray diffraction"],
+ "pdb_id":"3v1g",
+ "resolution":2.2,
+ "title":"Forestalling insulin fibrillation by insertion of a chiral clamp mechanism-based application of protein engineering to global health"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"3v1g",
+ "resolution":2.2,
+ "title":"Forestalling insulin fibrillation by insertion of a chiral clamp mechanism-based application of protein engineering to global health"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"5uu3",
+ "resolution":2.25,
+ "title":"Insulin with proline analog DfP at position B28 in the R6 state"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"5uss",
+ "resolution":2.061,
+ "title":"Insulin with proline analog PiP at position B28 in the R6 state"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"5uss",
+ "resolution":2.061,
+ "title":"Insulin with proline analog PiP at position B28 in the R6 state"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"5udp",
+ "resolution":1.348,
+ "title":"High resolution x-ray crystal structure of synthetic insulin lispro"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"5udp",
+ "resolution":1.348,
+ "title":"High resolution x-ray crystal structure of synthetic insulin lispro"},
+ {
+ "experimental_method":["X-ray diffraction"],
"pdb_id":"5mt9",
"resolution":1.88,
"title":"Human insulin in complex with serotonin and arginine"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"5uru",
- "resolution":2.41,
- "title":"Insulin with proline analog DhP at position B28 in the R6 state"},
+ "pdb_id":"5ems",
+ "resolution":2.3,
+ "title":"Crystal Structure of an iodinated insulin analog"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"5hpr",
+ "resolution":1.33,
+ "title":"Insulin with proline analog HyP at position B28 in the T2 state"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"5uu3",
- "resolution":2.25,
- "title":"Insulin with proline analog DfP at position B28 in the R6 state"},
+ "pdb_id":"5hpr",
+ "resolution":1.33,
+ "title":"Insulin with proline analog HyP at position B28 in the T2 state"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"3kq6",
"title":"Enhancing the Therapeutic Properties of a Protein by a Designed Zinc-Binding Site, Structural principles of a novel long-acting insulin analog"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4akj",
- "resolution":2.01,
- "title":"Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engineered acylated insulin"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"5uss",
- "resolution":2.061,
- "title":"Insulin with proline analog PiP at position B28 in the R6 state"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"5uss",
- "resolution":2.061,
- "title":"Insulin with proline analog PiP at position B28 in the R6 state"},
+ "pdb_id":"5mt3",
+ "resolution":2.02,
+ "title":"Human insulin in complex with serotonin and arginine"},
{
"experimental_method":["Electron Microscopy"],
"pdb_id":"6hn5",
"title":"Leucine-zippered human insulin receptor ectodomain with single bound insulin - \"upper\" membrane-distal part"},
{
"experimental_method":["X-ray diffraction"],
+ "pdb_id":"4wdi",
+ "resolution":2.313,
+ "title":"Weak TCR binding to an unstable insulin epitope drives type 1 diabetes"},
+ {
+ "experimental_method":["X-ray diffraction"],
"pdb_id":"2wc0",
"resolution":2.8,
"title":"crystal structure of human insulin degrading enzyme in complex with iodinated insulin"},
"resolution":2.8,
"title":"crystal structure of human insulin degrading enzyme in complex with iodinated insulin"},
{
- "experimental_method":["Electron Microscopy"],
- "pdb_id":"6sof",
- "resolution":4.3,
- "title":"human insulin receptor ectodomain bound by 4 insulin"},
- {
"experimental_method":["X-ray diffraction"],
"pdb_id":"6z7y",
"resolution":2.2,
"resolution":2.2,
"title":"Human insulin in complex with the analytical antibody OXI-005 Fab"},
{
+ "experimental_method":["Electron Microscopy"],
+ "pdb_id":"6sof",
+ "resolution":4.3,
+ "title":"human insulin receptor ectodomain bound by 4 insulin"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"3p2x",
+ "resolution":2.0,
+ "title":"Insulin fibrillation is the Janus face of induced fit. A chiaral clamp stabilizes the native state at the expense of activity"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"3p2x",
+ "resolution":2.0,
+ "title":"Insulin fibrillation is the Janus face of induced fit. A chiaral clamp stabilizes the native state at the expense of activity"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"3jsd",
+ "resolution":2.5,
+ "title":"Insulin's biosynthesis and activity have opposing structural requirements: a new factor in neonatal diabetes mellitus"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"3jsd",
+ "resolution":2.5,
+ "title":"Insulin's biosynthesis and activity have opposing structural requirements: a new factor in neonatal diabetes mellitus"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"2om1",
+ "resolution":1.97,
+ "title":"Structure of human insulin in presence of thiocyanate at pH 6.5"},
+ {
"experimental_method":["X-ray diffraction"],
"pdb_id":"2omh",
"resolution":1.36,
"title":"Structure of human insulin cocrystallized with ARG-12 peptide in presence of urea"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2omg",
- "resolution":1.52,
- "title":"Structure of human insulin cocrystallized with protamine and urea"},
- {
- "experimental_method":["X-ray diffraction"],
"pdb_id":"3fq9",
"resolution":1.35,
"title":"Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications"},
"title":"Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"3jsd",
- "resolution":2.5,
- "title":"Insulin's biosynthesis and activity have opposing structural requirements: a new factor in neonatal diabetes mellitus"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"3jsd",
- "resolution":2.5,
- "title":"Insulin's biosynthesis and activity have opposing structural requirements: a new factor in neonatal diabetes mellitus"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"4p65",
- "resolution":1.5,
- "title":"Crystal structure of an cyclohexylalanine substituted insulin analog."},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"4p65",
- "resolution":1.5,
- "title":"Crystal structure of an cyclohexylalanine substituted insulin analog."},
- {
- "experimental_method":["X-ray diffraction"],
"pdb_id":"3p33",
"resolution":2.3,
"title":"Insulin fibrillation is the Janus face of induced fit. A chiral clamp stabilizes the native state at the expense of activity"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"3p2x",
- "resolution":2.0,
- "title":"Insulin fibrillation is the Janus face of induced fit. A chiaral clamp stabilizes the native state at the expense of activity"},
+ "pdb_id":"2omg",
+ "resolution":1.52,
+ "title":"Structure of human insulin cocrystallized with protamine and urea"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"3p2x",
- "resolution":2.0,
- "title":"Insulin fibrillation is the Janus face of induced fit. A chiaral clamp stabilizes the native state at the expense of activity"},
+ "pdb_id":"1ben",
+ "resolution":1.4,
+ "title":"INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"1qiz",
"title":"HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH RESORCINOL"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"1ben",
- "resolution":1.4,
- "title":"INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE"},
+ "pdb_id":"4p65",
+ "resolution":1.5,
+ "title":"Crystal structure of an cyclohexylalanine substituted insulin analog."},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2oly",
- "resolution":1.7,
- "title":"Structure of human insulin in presence of urea at pH 7.0"},
+ "pdb_id":"4p65",
+ "resolution":1.5,
+ "title":"Crystal structure of an cyclohexylalanine substituted insulin analog."},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"2om1",
- "resolution":1.97,
- "title":"Structure of human insulin in presence of thiocyanate at pH 6.5"},
+ "pdb_id":"1lph",
+ "resolution":2.3,
+ "title":"LYS(B28)PRO(B29)-HUMAN INSULIN"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"6ck2",
- "resolution":2.25,
- "title":"Insulin analog containing a YB26W mutation"},
+ "pdb_id":"2oly",
+ "resolution":1.7,
+ "title":"Structure of human insulin in presence of urea at pH 7.0"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"6tyh",
"title":"Four-Disulfide Insulin Analog A22/B22"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"5mt3",
- "resolution":2.02,
- "title":"Human insulin in complex with serotonin and arginine"},
+ "pdb_id":"5uru",
+ "resolution":2.41,
+ "title":"Insulin with proline analog DhP at position B28 in the R6 state"},
+ {
+ "experimental_method":["Electron Microscopy"],
+ "pdb_id":"7bw8",
+ "resolution":3.8,
+ "title":"Cryo-EM Structure for the Insulin Binding Region in the Ectodomain of the Full-length Human Insulin Receptor in Complex with 1 Insulin"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"6ck2",
+ "resolution":2.25,
+ "title":"Insulin analog containing a YB26W mutation"},
+ {
+ "experimental_method":["Electron Microscopy"],
+ "pdb_id":"6bfc",
+ "resolution":3.7,
+ "title":"Cryo-EM structure of human insulin degrading enzyme in complex with insulin"},
+ {
+ "experimental_method":["Electron Microscopy"],
+ "pdb_id":"6b3q",
+ "resolution":3.7,
+ "title":"Cryo-EM structure of human insulin degrading enzyme in complex with insulin"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"6nwv",
"resolution":1.601,
"title":"Insulin Lispro Analog"},
{
+ "experimental_method":["Electron Microscopy"],
+ "pdb_id":"7bwa",
+ "resolution":4.9,
+ "title":"Cryo-EM Structure for the Ectodomain of the Full-length Human Insulin Receptor in Complex with 2 Insulin"},
+ {
"experimental_method":["X-ray diffraction"],
"pdb_id":"5hpu",
"resolution":2.2,
"title":"Insulin with proline analog HzP at position B28 in the R6 state"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4ajz",
- "resolution":1.8,
+ "pdb_id":"4akj",
+ "resolution":2.01,
"title":"Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engineered acylated insulin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"5mt9",
- "resolution":1.88,
- "title":"Human insulin in complex with serotonin and arginine"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"5uru",
- "resolution":2.41,
- "title":"Insulin with proline analog DhP at position B28 in the R6 state"},
+ "pdb_id":"4ajz",
+ "resolution":1.8,
+ "title":"Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engineered acylated insulin"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"5uu3",
"title":"Insulin with proline analog ThioP at position B28 in the R6 state"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"5bqq",
- "resolution":1.54,
- "title":"Human insulin with intra-chain chemical crosslink between modified B27 and B30"},
- {
- "experimental_method":["X-ray diffraction"],
"pdb_id":"5mam",
"resolution":2.2,
"title":"Human insulin in complex with serotonin"},
"title":"Human insulin in complex with serotonin"},
{
"experimental_method":["X-ray diffraction"],
- "pdb_id":"4akj",
- "resolution":2.01,
- "title":"Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engineered acylated insulin"},
+ "pdb_id":"5mt3",
+ "resolution":2.02,
+ "title":"Human insulin in complex with serotonin and arginine"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"5mt9",
+ "resolution":1.88,
+ "title":"Human insulin in complex with serotonin and arginine"},
+ {
+ "experimental_method":["X-ray diffraction"],
+ "pdb_id":"5bqq",
+ "resolution":1.54,
+ "title":"Human insulin with intra-chain chemical crosslink between modified B27 and B30"},
{
"experimental_method":["X-ray diffraction"],
"pdb_id":"1q4v",
"resolution":1.499,
"title":"Insulin co-crystallizes in the presence of it beta-cell chaperone sulfatide"},
{
- "experimental_method":["Electron Microscopy"],
- "pdb_id":"6sof",
- "resolution":4.3,
- "title":"human insulin receptor ectodomain bound by 4 insulin"},
- {
- "experimental_method":["Electron Microscopy"],
- "pdb_id":"6sof",
- "resolution":4.3,
- "title":"human insulin receptor ectodomain bound by 4 insulin"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"6z7y",
- "resolution":2.2,
- "title":"Human insulin in complex with the analytical antibody OXI-005 Fab"},
- {
"experimental_method":["X-ray diffraction"],
"pdb_id":"6z7y",
"resolution":2.2,
- "title":"Human insulin in complex with the analytical antibody OXI-005 Fab"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"1zeh",
- "resolution":1.5,
- "title":"STRUCTURE OF INSULIN"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"1zeh",
- "resolution":1.5,
- "title":"STRUCTURE OF INSULIN"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"1qiy",
- "resolution":2.3,
- "title":"HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH PHENOL"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"1qiy",
- "resolution":2.3,
- "title":"HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH PHENOL"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"2oly",
- "resolution":1.7,
- "title":"Structure of human insulin in presence of urea at pH 7.0"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"3rov",
- "resolution":2.3,
- "title":"Insulin's biosynthesis and activity have opposing structural requirements: a new factor in neonatal diabetes mellitus"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"3rov",
- "resolution":2.3,
- "title":"Insulin's biosynthesis and activity have opposing structural requirements: a new factor in neonatal diabetes mellitus"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"5bqq",
- "resolution":1.54,
- "title":"Human insulin with intra-chain chemical crosslink between modified B27 and B30"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"1q4v",
- "resolution":2.0,
- "title":"CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN INACTIVE CHIRAL ANALOGUE: IMPLICATIONS FOR THE MECHANISM OF RECEPTOR"},
- {
- "experimental_method":["Electron Microscopy"],
- "pdb_id":"6sof",
- "resolution":4.3,
- "title":"human insulin receptor ectodomain bound by 4 insulin"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"6z7w",
- "resolution":2.42,
- "title":"Human insulin in complex with the analytical antibody HUI-018 Fab"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"6z7w",
- "resolution":2.42,
- "title":"Human insulin in complex with the analytical antibody HUI-018 Fab"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"1zeg",
- "resolution":1.6,
- "title":"STRUCTURE OF B28 ASP INSULIN IN COMPLEX WITH PHENOL"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"5uqa",
- "resolution":1.3100024,
- "title":"Insulin with proline analog FzP at position B28 in the R6 state"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"6z7w",
- "resolution":2.42,
- "title":"Human insulin in complex with the analytical antibody HUI-018 Fab"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"6z7w",
- "resolution":2.42,
- "title":"Human insulin in complex with the analytical antibody HUI-018 Fab"},
- {
- "experimental_method":["X-ray diffraction"],
- "pdb_id":"1xda",
- "resolution":1.8,
- "title":"STRUCTURE OF INSULIN"}]
+ "title":"Human insulin in complex with the analytical antibody OXI-005 Fab"}]
}}
git://source.jalview.org / jalview.git / commitdiff